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With an ever-growing market and continual financial pressures associated with the 
prohibition of antibiotic growth promoters, the poultry industry has had to rapidly 
develop non-antibiotic alternatives to increase production yields. A possible alternative 
is yeast and its derivatives, such as the yeast cell wall (YCW), which have been 
proposed to confer a number of beneficial effects on the host animal. Here, the effect of 
YCW supplementation on the broiler chicken was investigated using a quantitative 
proteomic strategy, whereby serum was obtained from three groups of broilers fed with 
distinct YCW feed supplements or a control basal diet. Development of a novel reagent 
enabled application of Proteominer™ technology for sample preparation and subsequent 
comparative quantitative proteomic analysis revealed proteins which showed a 
significant change in abundance (n = 167 individual proteins; p <0.05); as well as 
proteins which were uniquely identified (n = 52) in, or absent (n = 37) from, YCW-fed 
treatment groups versus controls. An average of 7.1% of proteins showed changes in 
abundance with YCW supplementation. A number of effects of these YCW 
supplements including immunostimulation (via elevated complement protein detection), 
potential alterations in the oxidative status of the animal (e.g., glutathione peroxidase & 
catalase), stimulation of metabolic processes (e.g., differential abundance of 
glyceraldehyde-3-phosphate dehydrogenase), as well as evidence of a possible 
hepatoprotective effect (attenuated levels of serum α-glutathione s-transferase) by one 
YCW feed supplement, were observed. It is proposed that specific protein detection 
may be indicative of YCW efficacy to stimulate broiler immune status, i.e. may be 
biomarkers of YCW efficacy. In summary, this work has developed a novel technology 
for the preparation of high dynamic range proteomic samples for LC-MS/MS analysis, 
is part of the growing area of livestock proteomics and, importantly, provides evidential 













1.1 Overview of the Poultry Industry. 
Currently, the global poultry industry produces approximately 100 million tonnes of 
meat and 73 million tonnes of eggs per annum (Motte & Tempio, 2017). The 
consumption of poultry products has increased threefold since 1970 with a 5% increase 
in annual production compared to 2.8% for total meat produce. This growth has allowed 
poultry meat to now represent 35% of global meat consumption. This rapid growth is 
expected to continue, with production of poultry meat expected to reach 181 million 
tonnes by 2050 (Alexandratos & Bruinsma, 2012). 
 In 2016, upwards of 23 billion poultry animals were farmed, and these fall into 
one of three production systems; Broilers, Layers and Backyard (Gerber et al., 2013). 
Broilers are fully market-orientated chickens that have been selectively bred for meat 
production. They require high capital input but return high levels of flock productivity 
(Gerber et al., 2013). Improvements in the growth and efficiency of this production 
system have resulted in the consumer price index for poultry meat growing at half the 
rate of all other products between 1960 and 2004, which is likely to have been a factor 
in the recent growth (Zuidhof et al., 2014). Since first adapting genetic techniques to 
improve animal productivity in 1943, commercial breeding has seen massive 








1.2 The use of Antibiotic Growth Promoters in Food Animals. 
Antibiotics were first adopted as growth promoters in the 1950s after the discovery that 
their use could enhance growth efficiencies (Moore et al., 1946). With the use of 
antibiotic growth promoters (AGP), weight gain may be observed, however, the main 
effect can be seen in feed efficiency (Coates et al., 1955). A reduction in opportunistic 
pathogen infection, as well as sub-clinical infection, can also be seen with the use of 
AGPs (Dibner & Richards, 2005). The mode of action of AGP is via the modulation of 
gut microflora. This was shown in experiments by Coates et al. (1955) and (1963) 
which demonstrated that this enhancement of growth efficiency was not seen in germ-
free animals. Adoption of AGPs became the norm throughout the poultry industry from 
the 1950s onwards (Dibner & Richards, 2005). 
 In 1969, the Joint Committee on the Use of Antibiotics in Animal Husbandry 
and Veterinary Medicine recommended the discontinuation of a number of specific 
antibiotics due to antibiotic resistance concerns (Swann et al., 1969). Information 
regarding the emergence of antibiotic resistance continued to surface throughout the 
20th Century which led the World Health Organisation to publish two reports 
suggesting a link between antimicrobial growth promoter use in animal husbandry and 
antibiotic-resistant infection in humans, as well as recommending that Governments 
reduce the need for antimicrobials in animals (World Health Organization, 1997; World 
Health Organization, 2000). 
 Sweden was the first nation to adopt a ban of antimicrobials in 1986 (Wierup, 
2001). This was followed by a number of bans of specific AGPs, such as Avoparcin in 
Denmark in 1995 (Aarestrup et al., 2001) and the European Union (EU) with Council 
Directive 97/6/EC of 30 of January 1997 concerning additives in feeding-stuffs after a 
discovery of glycopeptide-resistant Enterococci (Bates et al., 1993). Further bans were 
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introduced in Denmark as well as the EU in 1999, with bans on vancomycin and a 
number of antimicrobials used also to treat humans. In 2000, antimicrobials were 
restricted to therapeutic use in Denmark (Dibner & Richards, 2005). 
 Bans on the use of antibiotics in animal husbandry were introduced in the EU in 
2006. The EU ratified Regulation (EC) No. 1831/2003 on additives for use in animal 
nutrition, which prohibited the use of coccidiostats and histomonostats. This came 
following statements by the Scientific Steering committee of the EU in 1999 and 2001 
that the use of antimicrobials as growth promoting agents should be phased out as soon 
as possible in an effort to curb antibiotic resistance. The regulation allowed for 
"sufficient time such that alternative products to replace those antibiotics be developed" 
(European Commission, 2003). A two-year phasing out period led to an outright ban of 
antibiotic use in animal nutrition in January 2006. 
In 2013 the United States Food and Drug Administration (FDA) issued a 
regulation that the "production use" of antibiotics should be eliminated in food-
producing animals in an attempt to reduce the development of antibiotic-resistant 
bacteria (Food and Drug Administration, 2013). This ban came into effect in January 
2017.  
1.3 Performance Enhancing Alternatives to Antibiotic Growth Promoters 
Regulation of the gut microbiome using prebiotics represents one alternative to the use 
of AGPs. These feed additives, or alternatives, have been seen to modulate the gut 
microbiota which can provide resistance to pathogenic bacteria as well as stimulate the 
immune system in a non-inflammatory manner thus improving the health of the animal 
and reducing the risk of food-borne disease (Gaggìa et al., 2010). 
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 Prebiotics are defined as non-digestible food ingredients that beneficially affect 
the host by selectively stimulating the growth and/or activity of one or a limited number 
of bacterial species in the colon (Gibson & Roberfroid, 1995). Dietary substrates must 
satisfy three criteria in order to be considered prebiotics: (i) the substrate must not be 
hydrolysed or absorbed in the stomach or small intestine, (ii) it must be selective for 
beneficial commensal bacteria in the colon and (iii) fermentation of the substrate should 
induce beneficial luminal/systemic effects within the host (Manning & Gibson, 2004). 
1.3.1 Yeast and Yeast Derivatives in Poultry Industry 
The use of yeast as a growth promoter was first reported in 1924 (Eckles et al., 1924). 
Since then, yeast and its derivatives have been adopted as prebiotic growth promoters 
into many food-animal diets including ruminants, pigs and poultry (Gao et al., 2003). 
 In the last number of decades, Yeast Cell Wall (YCW) products have been 
adopted in animal nutrition (Hooge, 2004). Approximately 30 - 60 % of YCW is 
composed of polysaccharides, of which the majority are β-glucans and 
mannanoligosaccharides (MOS). The remaining 40 - 70% of the YCW products are cell 
wall proteins, which are often complexed with MOS to yield mannoprotein complexes, 
lipids and chitin (Morales-Lopez et al., 2009). A representation of the yeast cell wall 















Figure 1.1: Schematic cross-section of the YCW showing major components (Kogan & 
Kocher, 2007). 
1.3.2 β-glucans 
β-glucans are naturally occurring polymers of glucose that are found in the cell wall of 
plants, bacteria and yeast. Typically found as either β-1, 3 glucan or β-1, 6 glucan these 
polysaccharides can have effects on the immune system of the host, and belong to a 
class of molecule known as biological response modifiers (Williams et al., 1996). 
Immunological effects of these molecules have been seen in many species, including the 
broiler chicken (Abel & Czop, 1992; Chae et al., 2006; Zokaeifar et al., 2012).  
 In the early stages of the life of chickens, the immune system is underdeveloped 
and inept. β-glucans have been linked to enhancement of protective immunity during 
these early stages (Cox et al., 2010). It has been suggested that many of these protective 
immunological effects are stimulated by the binding of β-glucans to monocyte and 
macrophage receptors which trigger an immunological cascade of events (Kogan & 




 Supplementation of poultry diet with these polysaccharides has been found to 
have effects on both the innate and adaptive responses (Guo et al., 2003). Proliferation 
and phagocytic activity of both macrophages and splenocytes have been seen to be 
improved in broiler chickens with β-glucan supplementation (Chen et al., 2003). An 
activation of the humoral response has also been seen with rises in IgA and IgG levels 
recorded (Zhang et al., 2008). T-cell levels were seen to be increased, with larger 
CD4+, CD8+, and CD4+:CD8+ T-cell populations found in β-glucan supplemented 
chickens (Chen et al., 2003; Chae et al., 2006). Several cytokines were found to be 
upregulated with β-glucan supplementation such as interleukin (IL)-1 (Gao et al., 2003), 
IL-2 and Interferon (Zhang et al., 2008). Increases in the size of primary and secondary 
lymphoid organs have also been seen (Gao et al., 2003; Zhang, et al., 2008). Fungal 
components have been previously noted as potent activators of the complement system 
(Dlabač & Kawasaki, 1994; Bohn & BeMiller, 1995; Levitz, 2010; Song et al., 2014; 
Mensink et al., 2015).  
1.3.3 Mannose Oligosaccharide 
Mannose Oligosaccharide (MOS) is an indigestible sugar derived from the cell wall of a 
number of yeast species that has been linked to a wide variety of health benefits 
(Charachar et al., 2017). These benefits include reducing the levels of pathogenic 
bacteria in the gut (Charachar et al., 2017), enhancing growth of beneficial bacteria 
(Abel & Czop, 1992) and modulating the immune response (Shashidhara & 
Devegowda, 2003). 
 MOS have been found to modulate the gut microbiome by acting as high affinity 
ligands offering competitive binding sites for mannose-specific type-1 fimbriae of 
pathogenic bacteria (Spring et al., 2000) and stimulating the production of mucins by 
goblet cells found in the digestive tract (Charachar et al., 2017). Mucins are the 
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glycoprotein constituent of mucus (Pelaseyed et al., 2014) which are involved in the 
binding and clearance of bacteria from the intestine. This reduction in pathogenic 
bacteria can create a more favourable environment for beneficial bacteria such as 
Lactobacillus and Bifidobacterium spp. in the broiler intestine (Baurhoo et al., 2009). 
 The addition of MOS to the diet of broiler chickens can increase immune 
potential with improvements seen in cellular, humoral and mucosal immunities 
(Gomez-Verduzco et al., 2009; Ozpinar et al., 2010). Much like the effects of β-
glucans, much of the immunostimulatory effect of MOS is mediated by the activation of 
macrophages. These macrophages exist in the intestine of poultry as part of the gut-
associated lymphoid tissue and recognise pathogens through pathogen associated 
molecular pattern (PAMP) receptors (Shashidhara & Devegowda, 2003). Mannans from 
the YCW can bind these PAMP receptors which can lead to an improved cellular 
immune response (Chachar et al., 2017). Ozpinar et al. (2010) showed significantly 
higher levels of IgG levels in broiler chickens supplemented with MOS compared to 
those supplemented with vitamin-based supplements.  
 The physiological effects of MOS can translate into improved performance of 
broilers. A number of studies have suggested that birds fed MOS as a supplement to a 
basal diet had significantly improved weight gain when compared to those fed the basal 





1.3.4 Potential of Essential Oils in Poultry Nutrition 
Essential oils (EO) are a complex mix of plant secondary metabolites which are 
extracted from plant material such as roots, buds, leaves, flowers, bark, herbs, seeds, 
wood, and fruits (Greathead, 2003; Brenes & Roura, 2010). These products are often 
used as an additive in animal feed supplementation (Windisch et al., 2008; Gong et al., 
2014; Zou et al., 2016) and have been reported to convey a number of beneficial effects 
to the host animal. Natustat®, one of the YCW feed products used in this study, 
contains EO. 
 These phytogenic products have been previously reported to enhance the total 
antioxidative capacity of the host (Zeng et al., 2015), stimulate the host immune system 
(Zeng et al., 2015), stimulate digestive processes (Acamovic & Brooker, 2005) and 
regulate gut microflora, reducing levels of pathogenic bacteria (Jang et al., 2007; 
Windisch et al., 2008).  
1.3.5 Role of Selenium in Poultry Nutrition 
Selenium is an essential element in poultry nutrition and due to falling levels of 
selenium in soil due to commercial cropping, supplementation is essential in poultry 
nutrition (Peric et al., 2009). 
 There are two main sources of selenium in poultry diet: inorganic selenium in 
the form of selenite or selenate and organic selenium in the form of selenomethionine 
(SeMet) (Surai & Fisinin, 2014). Organic selenium has been reported to be more 
bioavailable than its inorganic counterpart (Lönnerdal et al., 2017). This trace element 
is essential for the production of selenoproteins which can participate in a number of 
physiological processes in production animals (Dalgaard et al., 2018).  
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 Selenium has been linked to the activation, proliferation and differentiation of 
cells that drive both the adaptive and innate immune responses (Huang et al., 2012). 
Selenium deficiency was shown to impair thymus development in broiler chickens 
which reduced CD3+ and CD3+CD8+ T cell frequencies (Peng et al., 2011; Chang et 
al., 1994). Glutathione peroxidase is involved in signalling, peroxide scavenging and 
maintaining cellular redox homeostasis. Three of the eight glutathione peroxidases 
found in mammals contain selenocysteine residues at their catalytic site (Lubos et al., 
2015). Synthesis of selenoproteins, such as these glutathione peroxidases, is regulated 
by the availability of selenium and, in times of deficiency, synthesis of certain 
selenoproteins is reduced in favour of others (Howard et al., 2013; Peric et al., 2009). 
Macrophages stimulate cellular activation by controlling actin disassembly and re-
assembly through the expression of methionine-R-sulfoxide reductase B1. This 
selenoprotein controls the state of actin through oxidation and reduction of methionine 
(Lee et al., 2013). Selenium deficiency in poultry can lead to liver necrosis and 
muscular dystrophy (Koller & Exon, 1986). 
1.4 Proteomics 
Proteomics is the identification and analysis of the total protein in a biological system 
(Tsai et al., 2015). Proteins provide a wealth of information about the status of an 
organism as they are direct functional molecules in living organisms (Zhang et al., 
2013). The examination of protein abundance, post-translational modification, structure 
as well as protein-protein interaction (Wright et al., 2012) has allowed proteomics to 
become a powerful tool in the analysis of health status and disease.  
 Proteomic workflows involve two stages: separation of the proteomic sample 
through gel-based technologies or chromatographic techniques, and protein/peptide 
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identification using mass spectrometry(MS). Data analysis is then carried out using 
bioanalytical software and proteomic databases  (Ramasamy et al., 2014). 
 Proteomic analyses can be broken down into broad strategies, top-down and 
bottom-up (Ramasamy et al., 2014). Top-down proteomics involves the analysis of 
specific intact proteins without proteolytic digestion (Campos & de Almeida, 2016). 
This technique has advantages such as post-translational modification and protein 
isoform identification (Zhang et al., 2013). Bottom-up proteomics involves the analysis 
of complex proteomic samples using a combination of enzymatic digestion and high 
resolution  chromatographic or electrophoretic techniques to deconvolute  and analyse 
protein samples  (Bogdanov & Smith, 2005; Gevaert et al., 2007). Protein identification 
is then achieved by comparing mass spectra of fragmented peptides to the theoretical in 
silico digestion of the protein database (Zhang et al., 2013). Bottom-up proteomic 
analysis has significant advantages in complex proteomic samples, such as overcoming 
the analytical challenges of analysing intact protein, which has led to it becoming the 
more universally adopted in modern proteomic analysis (Zhang et al., 2013) 
 There are two predominantly used separation techniques in modern quantitative 
proteomics (Zhang et al., 2013), shown in Figure 1.2: Two dimensional polyacrylamide 
gel electrophoresis (2D-PAGE) coupled with an MS technique such as Matrix Assisted 
Laser Desorption/Ionization (MALDI) MS or Liquid Chromatography (LC) MS (Banks 
et al., 2000), or Liquid Chromatography with Tandem Mass Spectrometry (LC-
MS/MS). 2D-PAGE was the first platform used in quantitative proteomics though 
limitations such as low resolution, labour intensive workflow and inadequate detection 
of low abundance proteins (LAP) in samples with large dynamic range, as well as the 
advancement of MS technology, have led LC-MS/MS-based analysis to become the 
preferred method (Zhang et al., 2013). LC-MS/MS has now become the driving force in 
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the proteomic analysis of complex samples, delivering high throughput, in-depth 
proteomic analysis (Griffiths & Wang, 2009; Aebersold & Mann, 2003) and these 




















 Label-free Quantitative (LFQ) proteomics has emerged as a high-throughput 
method for clinical proteomics (Griffiths & Wang, 2009). LFQ proteomics employs one 
of two methods to quantify protein abundance within a sample: Spectral Counting or 
Ion Intensity. In Spectral Counting, the protein abundance is correlated with the 
frequency of peptide spectral matches (Washburn et al., 2001; Liu et al., 2004; Gilchrist 
et al., 2006). A protein abundance index (PAI) is constructed for each protein, which is 
the number of observed peptides divided by the number of theoretically identified 
peptides. This number is then converted to exponentially modified PAI (emPAI) which 
is used by bioanalytical software for protein quantification (Ishihama et al., 2005). The 
Ion Intensity approach utilises the linear correlation between a peptide's peak area and 
its relative abundance to quantify changes in protein abundance. Peak areas can then be 
compared between conditions to give relative protein abundance (Bondarenko et al., 
2002; Chelius & Bondarenko, 2002). 
 Following LC-MS/MS, analysis algorithms must be used to annotate identified 
peptides and quantify protein changes. These algorithms can be developed or obtained 
as part of proteomic data analysis software packages (Drabik & Silberring, 2016). One 
such software package is MaxQuant. Maxquant is freely available software from the 
Max Planck Institue of Biochemistry (Germany). This software quantifies proteins 
using maximum peptide ratio information from extracted peptide ion signal intensities 
to accurately quantify fold changes in protein intensity over several orders of magnitude 




1.5 Farm Animal Proteomics 
Recently, proteomic investigation in farm animals has increased with a number of 
reviews published highlighting its potential (Bendixen et al., 2011; Almeida & 
Bendixen, 2012; Di Girolamo et al., 2014; Almeida et al., 2015). This is largely due to 
the creation of the European Cooperation in Science and Technology (COST) action on 
Farm Animal Proteomics (FAP) which was formed to demonstrate the role proteomics 
can have in farm animal research (Rodrigues et al., 2012). Despite this, farm animal 
proteomics still remains a minor component of proteomic study as a whole (Bili et al., 
2018). Livestock proteomic studies have largely focused on the understanding of traits 
linked to the animal welfare as well as the quality of food products such as meat and 
milk (Di Girolamo et al., 2014; Almeida et al., 2015). 
1.5.1 Avian Proteomics 
Despite the publication of the Gallus gallus genome in 2005 (International Chicken 
Genome Sequencing Consortium, 2005) and fowl species being a major food source to 
humans, avian proteomics has fallen behind that of other livestock  (Almeida et al., 
2015).  
 Early avian proteomic research used MS to characterise tissues and structures, 
such as the components of the egg (Mann, 2007; D’Ambrosio et al., 2008; Mann & 
Mann, 2011; Farinazzo et al., 2009; Mann & Mann, 2008) and muscle meat (Bendixen, 
2005). With developments in mass spectrometry and bioinformatic technologies in the 
last decade leading to advances in quantitative proteomics (Feng et al., 2017), 
comparative proteomics has come to the forefront of proteomic research.  
 With these advances in proteomic technologies, a number of comparative avian 
proteomic investigations have been conducted in recent years. Proteomic analysis has 
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been used to investigate the effects of the stress of restraint and transport on chickens, 
results showed differential expression of proteins involved in cytoskeleton structure and 
carbohydrate metabolism (Hazard et al., 2011). The effects of heat stress on broiler 
chickens was assessed by Zeng et al. (2013) revealing heat shock proteins HSP10 and 
HSP70 as potential biomarkers for heat stress in Muscovy and Pekin ducks. A 
proteomic study conducted by Zheng et al. (2014) on lean and obese Pekin ducks 
revealed a number of proteins related to glycolysis and ATP synthesis were increased in 
abundance in the obese group. Comparative proteomics has also been used to 
differentiate meat from different livestock species. Differences in the primary structure 
of proteins such as serum albumin, apolipoprotein and heat shock protein 27 were seen, 
which could be used as biomarkers for meat origin (Montowska & Pospiech, 2013).  
1.6 Serum Proteomics 
The blood of an animal flows through the entire body and contains a wealth of 
information regarding its pathological and physiological condition. Serum is a blood 
derivative which lacks cells and clotting factors (Issaq et al., 2007; Biosa et al., 2011). 
Serum proteins often originate from a variety of tissue and blood cells due to leakage or 
secretion which can provide valuable information on the status of the animal (Hu et al., 
2006).  
 Serum proteomics in livestock can be a useful tool for monitoring health status 
(Di Girolamo et al., 2014). Investigations involving bovine, ovine, swine, avian and 
equine sera samples have been conducted on the effects of stress, infection as well as 
disease. Serum proteomic investigations by Marco-Ramell et al. (2011) and (2012) 
revealed changes in the oxidative status of cows in response to a harsher rearing habitat 
and elucidated actin as a potential biomarker for stress related to stocking density in 
pigs. Research conducted into Mycobacterium infection in cattle, using serum 
16 
 
proteomics revealed differential expression of α-1-acid glycoprotein and vitamin D-
precursor in infected cows (Seth et al., 2009). Serum proteomics has also been used to 
investigate a number of livestock diseases such as Spontaneous Equine Uveitis, which 
was investigated by Zipplies et al., (2009). Results showed reductions in the serum 
levels of Complement C1q and C4 as well as antithrombin in horses infected with this 
disease (Zipplies et al., 2009). Serum proteomic analysis of cows suffering from milk 
fever revealed upregulation of a number of proteins including serine peptidase inhibitor 
and endopin 2B (Xia et al., 2012). 
 A relatively small number of comparative proteomic studies have been 
conducted on avian serum in recent years (Table 1.1). Previous studies have principally 
focused on development, infection and disease. As far as could be found in the 
literature, no investigations using avian serum proteomics have been published on the 
effects of feed products on the broiler chicken.
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Table 1.1. Previous proteomic studies conducted on avian serum/plasma. 
Serum Proteomic Study Year Findings Reference 
Analysis of the effects of Lipopolysaccharide (LPS) 
on Broiler Chickens using Plasma proteomics. 
2018 Pathways related with protein activation cascade and heterotopic 
cell-cell adhesion were affected by LPS-challenge. 
Horvatić et al., 2018 
Analysis of the effects of LPS on Broiler Chickens 
using Plasma proteomics. 
2016 Alterations in the abundance of proteins involved in 
immunomodulation, cytokine changes and defence mechanisms. 
Packialakshmi et al., 
2016a 
Analysis of the effects of Femoral Head Necrosis on 
Broiler Chickens using Plasma proteomics. 
2016 Alterations in the abundance of proteins involved in 
Immunomodulation, nutrient transport and antimicrobial activity. 
Packialakshmi et al., 
2016b 
Analysis of the effects of Femoral Head Necrosis on 
Broiler Chickens using Plasma proteomics. 
2015 Alterations in the abundance of proteins involved in transcription, 
angiogenesis and walking behaviour. 
Packialakshmi et al., 
2015 
Analysis of the effects of three strains of Eimeria on 
Broiler Chickens using serum proteomics. 
2011 Elucidation of several candidate markers for early detection of E. 
acervulina infection. 
Gilbert et al., 2011 
Analysis of the effects of ovarian adenocarcinoma on 
Broiler Chickens using plasma proteomics. 
2010 Ovomacroglobulin was increased in abundance across all time 
points in adenocarcinoma affected subject. 
Hawkridge et al., 
2010 
Analysis of the effects of Avian Pathogenic E. coli 
(APEC) on Broiler Chickens using serum proteomics. 
2008 Outer Membrane Protein A was increased in abundance with 
APEC infection. 
Tyler et al., 2008 
Investigation into changes in proteome of laying hens 
at different developmental stages. 
2006 Alterations in the abundance of proteins involved in egg 
production  
Huang et al., 2006 
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1.6.1 Challenges in Serum Proteomics 
One of the largest obstacles to serum proteomics is the large dynamic range of protein 
concentration. Current estimations are that protein concentration spans 10 orders of 
magnitude in serum samples, with biomarkers of disease and health status most often 
found in relatively low concentrations (Issaq et al., 2007). Typical serum protein 
concentration in poultry has been described between 36 and 55 mg/ml (Bounous et al., 
2000) with the 22 most abundant proteins representing 99% of the total serum protein 
(Issaq et al., 2007). Detection of lower abundance proteins (LAP) by MS technology 
can be obscured by the presence of high abundance proteins (HAP), such as serum 
albumin in the case of serum analysis (Anderson & Anderson, 2002; Ray et al., 2011).  
 This suppression in detection of LAP occurs due to the mode of action of MS 
technologies. When ionised peptides enter the mass spectrometer, the most abundant 
peptides are isolated, individually fragmented and the mass/charge ratio of these 
daughter ions is obtained (MS/MS scan). The data obtained from these MS/MS scans is 
then used by bioanalysis software to predict peptide sequences. The next set of most 
abundant ions are then determined and separated for MS/MS and this process is 
repeated throughout the MS analysis. An ion exclusion list is collected to ensure the 
most abundant ions are not repeatedly collected for MS/MS. A highly complex 
proteomic sample with large dynamic range will have thousands of peptide ions 
detected in each MS scan resulting in MS/MS scans on a small percentage of the total 
ions present. This can result in excellent coverage of HAP but poor identification of 
LAP (Huber et al., 2003; Brunet et al., 2004; Reinhardt & Lippolis, 2006; Zolotarjova 
et al., 2008; Lippolis & Nally, 2018). 
 Hence, in order to attain adequate coverage of the serum proteome, the use of 
serum pre-fractionation to selectively deplete interfering HAP or enrichment techniques 
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to augment LAP is vital (Millioni et al., 2011; Doucette et al., 2011). These steps must 
have good reproducibility and reasonable cost and time effectiveness to allow sufficient 
number of test sample preparations (Baiwir et al., 2015) 
1.6.2 Methods for reducing dynamic range in the serum proteome 
The two main approaches in dynamic range reduction are selective reduction of specific 
HAP and enrichment of LAP using combinatorial ligand libraries (Zhang et al., 2014). 
 The reduction of specific HAP approach exploits the disparity in serum protein 
concentration in which a small number of proteins are at extremely high concentration 
(Zheng et al., 2014) and reduction of these specific HAP can improve the detection of 
lower abundance proteins in serum (Pieper et al., 2003; Echan et al., 2005). Reduction 
of specific HAP is typically achieved using commercial immunodepletion (ID) kits 
capable of binding and depleting the 7 (Hu-7, Agilent Technologies), 14 (Seppro IgY14, 
Sigma Aldrich) (MARS Hu-14, Agilent Technologies) or 20 (Proteoprep20, Sigma) 
most abundant serum proteins (Millioni et al., 2011). However, due to the lack of 
suitable antibodies for most animal species (Di Girolamo et al., 2014; Henning et al., 
2015), the ID approach is often not an option for use with animal serum. Production of 
kits for the major farm animals could be a valuable aid in livestock biomarker discovery 
(Almeida et al., 2015). 
 Combinatorial peptide ligand libraries (CPLL) are made up of highly diverse 
synthetic hexapeptides capable of binding most, if not all of any given proteome and 
enriching LAP (Righetti et al., 2012; Righetti et al., 2015). These hexapeptide ligands 
are bound to poly(hydroxymethacrylate) substrate beads, in a 1:1 peptide:bead ratio 
(Righetti & Boschetti, 2007; Marco-Ramell & Bassols, 2010). These peptide ligands are 
synthetically produced through a 'split, couple, randomise' procedure. This procedure 
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randomly generates peptide ligands using 20 amino acids, theoretically resulting in 64 
million different ligands bound to individual beads (Dowling et al., 2015). Hexapeptide 
ligands are assumed at equimolar amounts and due to the limited number of ligand-
bound beads, HAP saturate their equivalent ligands and surplus free protein is eluted 
(Zheng et al., 2014). Lower abundant proteins, which have not saturated their 
corresponding ligands, consequentially become quantitatively bound (Gianazza et al., 
2016) and the dynamic range of the proteomic sample, reduced (Capriotti et al., 2012). 
The enriched sample can then be eluted from their equivalent ligands yielding a 
proteomic sample with reduced dynamic range. 
The first use of these ligand libraries in a proteomic study was published in 2005 
(Thulasiraman et al., 2005), and since then they have been used in the proteomic 
enrichment of many sample types such as: urine (Castagna et al., 2005), red blood cells 
(Roux-Dalvai et al., 2008), chicken egg white (D’Ambrosio et al., 2008), plasma 
(Dowling et al., 2015) and serum (Sennels et al., 2007; Baiwir et al., 2015; de Jesus et 
al., 2017). 
 Proteominer™ (Bio-Rad Laboratories, CA, USA) is a commercial CPLL based 
protein enrichment technology capable of 'amplifying' lower abundance proteins in 
complex proteomic mixtures (Righetti et al., 2006; Boschetti et al., 2007; Righetti & 
Boschetti, 2007; Boschetti & Righetti, 2008) and allows species-independent 
enrichment of minor serum components (Righetti & Boschetti, 2007; Marco-Ramell & 













Figure 1.3: Representation of the reduction of the dynamic range of a proteomic sample 
using Proteominer™ technology. Adapted from Bio-Rad Laboratories, Inc 
representation of Proteominer™ technology. 
 
Using CPLL as the method of dynamic range reduction, serum proteomics will be 
carried out on serum samples obtained from broilers fed a diet supplemented with one 
of three YCW-based products. This novel work could elucidate in vivo effects of the 
YCW and lead to advancements in the field of livestock feed supplementation.  
The objectives of the work presented in this thesis are to: 
i. Develop and optimise a reproducible method for the preparation and quantitative 
proteomic analysis of avian serum. 
ii. Through serum proteomics, examine the effects of YCW feed on broiler 
chickens, through comparison with a control basal feed. 































All products listed were obtained from Sigma-Aldrich Chemical Co. Ltd (U.K.) unless 
otherwise stated. 
2.1.1 Solutions for pH Adjustment 
2.1.1.1 5 M Hydrochloric Acid (HCl) 
Hydrochloric acid (43.64 ml) was added to deionised water (40 ml) in a glass graduated 
cylinder. The final volume was adjusted to 100 ml with deionised water. The solution 
was stored at room temperature. 
2.1.1.2 5 M Sodium Hydroxide (NaOH) 
NaOH (20 g) was added to deionised water (80 ml). The solution was mixed and 
brought to a final volume of 100 ml with deionised water. The solution was stored at 
room temperature. 
2.1.2 Serum Enrichment Reagents. 
2.1.2.1 ProteoMiner™ Protein Enrichment Kit - Small Capacity (163-3006; 
BioRad) 
Each kit contains 10 small capacity ProteoMiner™ spin columns, Wash Buffer (50 ml) 
(Phosphate Buffered Saline), Elution Reagent (8 M Urea, 2% 3-[(3-Cholamidopropyl) 
dimethylammonio]-1-propanesulfonate hydrate (CHAPS)) (Lyophilised), Elution 
Reagent Rehydration Buffer (5 ml) (5% Acetic Acid). Capless collection tubes x 20. 
Capped collection tubes x 10. Kit stored at 4°C. 
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2.1.2.2 0.1 M Trizma® hydrochloride 
Trizma
®
 hydrochloride (1.57g) was dissolved in deionised water (80 ml).  The solution 
was then adjusted to 100 ml using deionised water. The solution was stored at room 
temperature. 
2.1.2.3 0.1 M Trizma® base  
Trizma
®
 Base (1.21g) was dissolved in deionised water (80 ml).  The solution was then 
adjusted to 100 ml using deionised water. The solution was stored at room temperature. 
2.1.2.4 0.1 M Trizma® pH 8.0 
0.1 M Trizma
®
 base (50 ml) (Section 2.1.2.3) was adjusted to pH 8.0 using 0.1 M 
Trizma® hydrochloride (Section 2.1.2.2). The solution was stored at room temperature. 
2.1.2.5 LC-MS/MS Compatible Reagent (LCR) 
6M Urea (36 g), 2M Thiourea (14.4 g) were dissolved in 0.1 M Trizma® pH 8.0 
(Section 2.1.2.4) (40 ml). The solution was then made up to 50 ml using 0.1 M Trizma® 
pH 8.0 (Section 2.1.2.4) The solution was stored at room temperature.  





 hydrochloride (2.35 g) was dissolved in deionised water (80 ml).  The solution 
was then adjusted to 100 ml using deionised water. The solution was stored at room 
temperature. 
2.1.2.7 0.15 M Trizma® base 
Trizma
®
 Base (1.82 g) was dissolved in deionised water (80 ml).  The solution was then 
adjusted to 100 ml using deionised water. The solution was stored at room temperature. 
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2.1.2.8 0.15 M Trizma® pH 9.0 
0.15 M Trizma
®
 base (50 ml) (Section 2.1.2.7) was adjusted to pH 9.0 using 0.15 M 
Trizma
®
 hydrochloride (Section 2.1.2.6). The solution was stored at room temperature. 
2.1.2.9 Label-Free solubilisation Buffer  
8 M Urea (24 g) was dissolved in 0.15 M Trizma
®
 buffer pH 9.0 (section 2.1.2.8) (40 
ml). The solution was then made up to 50 ml using 0.15 M Trizma
®
 buffer pH 9.0. The 
solution was stored at room temperature. 
2.1.2.10 Sample Buffer 
Acetonitrile (10 ml) and Trifluoroacetic Acid (TFA) (1 ml) were added to deionised 
water (30 ml). The solution was then made up to 50 ml using deionised water. The 
solution was stored at room temperature. 
2.1.3 Protein Digestion Reagents 
2.1.3.1 50 mM Ammonium Bicarbonate (NH4HCO3)  
NH4HCO3 (197 mg) was dissolved in deionised water (50 ml). The solution was 
prepared immediately before use. 
2.1.3.2 0.05 M Dithiothreitol (DTT)  
DTT (77 mg) was dissolved in 50 mM Ammonium Bicarbonate (1 ml) (Section 
2.1.3.1). The solution was then diluted one in ten by adding 0.1 ml of the DTT solution 
to 0.9 ml 50 mM Ammonium Bicarbonate buffer. The solution was prepared 
immediately before use. 
2.1.3.3 0.11 M Iodoacetamide (IAA) 
IAA (102 mg) was dissolved in 50 mM Ammonium Bicarbonate (1 ml) (Section 
2.1.3.1).  The solution was then diluted one in ten by adding 0.1 ml of the IAA solution 
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to 0.9 ml 50 mM Ammonium Bicarbonate buffer. The solution was prepared 
immediately before use and protected from light. 
2.1.3.4 Lys-C (0.25 μg/μl) 
Sequencing Grade Lys-C (20 μg) (90051 Thermo Scientific) was dissolved in 80 μl of 
deionised water. The solution was kept on ice until use. Remaining solution was 
aliquoted and snap-frozen using liquid nitrogen. Snap-frozen aliquots were stored at -
20°C. 
2.1.3.5 Trypsin (0.25μg/μl) 
Sequencing Grade Trypsin (20μg) (V5111 Promega) was dissolved in 50 mM acetic 
acid (80 μl) (supplied with Trypsin). The solution was kept on ice until use. Remaining 
solution was aliquoted and snap-frozen using liquid nitrogen. Snap-frozen aliquots were 
stored at -20°C. 
2.1.3.6 0.25% (w/v) ProteaseMax™ 
ProteaseMax™ (1 mg) (Promega) was dissolved in 50 mM Ammonium Bicarbonate 
(2.5 ml). The solution was kept on ice until use. Remaining solution was aliquoted and 
snap frozen using liquid nitrogen. Snap frozen aliquots were stored at -20°C. 
2.1.4 Zip-tipping Reagents 
2.1.4.1 Zip-tip Resuspension Buffer 
TFA (5 μl) was added to deionised water (995 μl). The solution was prepared 
immediately before use. 
2.1.4.2 Zip-tip Wetting Buffer 
TFA (1 μl) was added to LC-MS grade Acetonitrile (800 μl) and deionised water (199 
μl). The solution was prepared immediately before use. 
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2.1.4.3 Zip-tip Equilibration Buffer 
TFA (1 μl) was added to deionised water (999 μl). The solution was prepared 
immediately before use. 
2.1.4.4 Zip-tip Wash Buffer 
TFA (1 μl) was added to deionised water (999 μl). The solution was prepared 
immediately before use. 
2.1.4.5 Zip-tip Elution Buffer 
TFA (1 μl) was added to LC-MS grade Acetonitrile (600 μl) and deionised water (399 
μl). The solution was prepared immediately before use. 
2.1.5 Q-Exactive: LC-MS/MS Solvents 
2.1.5.1 Solvent A: 0.1% (v/v) TFA in Acetonitrile (3%(v/v)) 
LC-MS grade Acetonitrile (30 ml) and TFA (1 ml) were added to deionised water (969 
ml). The solution was prepared immediately before use. 
2.1.5.2 Solvent B: 0.1% (v/v) TFA in Acetonitrile (80% (v/v)) 
Deionised water 199 ml and TFA (1 ml) were added to LC-MS grade Acetonitrile (800 
ml). The solution was prepared immediately before use. 
2.1.6 Protein Characterisation Reagents 
2.1.6.1 Phosphate Buffered Saline (PBS) 
Ten PBS tablets (Oxoid) were dissolved in deionised water (1L). The solution was 
sterilised by autoclaving at 121°C for 15 min and stored at room temperature. 
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2.1.6.2 Bradford Solution 
Bradford reagent (BioRad) was diluted 1/5 using Phosphate Buffered Saline (PBS) 
Section (2.1.6.1). This solution was prepared immediately before use. 
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2.2 Methods  
2.2.1 Experimental Design, Sample Collection and Preservation  
A total of 492 day-of-hatch male broiler chickens were used in the poultry feeding trial. 
Clean concrete-floor pens were used to house the birds in a medium scale trial facility 
on-site at Agri-Food Biosciences Institute (AFBI) (Belfast, UK). Animals were 
randomly split into four groups of 3 pens, with 12 pens in total (41 birds/pen; 123 
birds/group) using a randomized complete block design. The pens were divided into 
four groups: group 1, fed a basal diet; group 2-4, fed a basal diet which included 
supplements 1, 2 and 3 respectively, at the manufacturers recommended inclusion levels 
(supplement 1 = Natustat
®
 (Alltech Inc. supplement 2 = Actigen
®
-pak (Alltech Inc.), 
supplement 3 = PowerTract
®
 (Alltech Inc.)). These supplements were mannan-rich 
fractions extracted from the yeast cell wall of Saccharomyces cerevisiae. Basal diets 
were prepared by a commercial feed mill and consisted primarily of wheat and soybean 
meal, as outlined in Table 2.1. Starter diets were fed from day 0 to day 10, grower diets 
from day 11-25 and finisher diets, day 26 to day 35. Feed and water were provided ad 
libitum throughout the study. Each pen was dressed with fresh litter for bedding from 
day zero. The temperature was initially set at 30
o
C per day up to day 10 and then 
decreased linearly by 1 
o
C every second day. During the experiment, the birds received 
a lighting regimen of 16 h light and 8 h darkness until day 35. All conditions were kept 
uniform for all four groups. On days 7, 21 and 35, blood samples from necropsied birds 
were collected into 100 ml sterile sample cups (75.562.105; Sarstedt) and then 
transferred to BD Vacutainer
®
 blood collection tubes using 10 ml wide-bore serological 
pipettes (86.1688.010; Sarstedt). The whole blood was allowed to clot at room 
temperature for 30 – 60 min. The clot was removed by centrifugation at 4500 rpm for 
10 min at 4 C. The resulting serum supernatant was apportioned into 0.5 ml aliquots 
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and snap frozen using liquid nitrogen. Aliquots were stored at -80 C and thawed on ice 
before use. These steps are shown in Figure 2.1. All procedures were subject to the 
approval of the local Animal Welfare Ethics Review Board and subsequent approval by 
a Home Office Inspector. All procedures were carried out under the strict guidelines of 
the Animal (Scientific Procedures) Act 1986 (Corrigan & Corcionivoschi, 2017).
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Table 2.1. Basal diet composition of starter, grower and finisher rations, obtained from 
Corrigan & Corcionivoschi (2017). 
Ingredients Starter  Grower Finisher 
Wheat 54.62 57.55 61.30 
Soya 12.00 12.00 12.00 
Soybean meal 25.00 21.00 17.00 
Limestone 0.72 0.70 0.50 
Di-calcium phosphate  1.65 2.00 2.15 
Soyabean oil 4.00 5.00 5.50 
Salt 0.20 0.20 0.20 
Sodium bicarbonate 0.20 0.17 0.16 
DL-Methionine 0.49 0.44 0.38 
L-Lysine 0.37 0.32 0.28 
Threonine 0.25 0.13 0.03 
Vitamin-mineral premix 0.50 0.50 0.50 
Nutrient analysis % or as 
indicated 
      
Metabolizable Energy 
(Kcal/kg) 
2999.00 3081.00 3133.80 
Crude Protein 23.12 21.53 20.04 
Lysine 1.45 1.31 1.17 
Methionine + Cysteine 1.09 1.00 0.91 
Calcium 0.97 0.91 0.85 
Available Phosphorous 0.49 0.41 0.41 
Vitamin-Mineral Premix       
Copper (mg) 16 16 16 
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Iodine (mg) 1.1 1.1 1.1 
Iron (mg) 30 30 30 
Manganese (mg) 110 110 110 
Selenium (mg) 0.3 0.3 0.3 
Zink (mg) 105 105 105 
Synergen (g) 200 200 200 
Vitamin A (IU) 13000 11000 10000 
Vitamin D3 (IU) 5000 4750 4500 
Vitamin E (IU) 80 60 50 
Vitamin K (mg) 3 3 2.5 
Thiamin (B1) (mg) 3 2.5 2 
Riboflavin (B2) (mg) 9 7 6 
Niacin (mg) 60 55 50 
Pantothenic Acid (mg) 20 15 12 
Pyridoxine (B6) mg 5 4 3 
Biotin (mg) 0.25 0.225 0.2 
Folic Acid (mg) 2 1.8 1.6 
Vitamin B12 (µg) 200 175 150 
Vitamin C (mg) 200 200 200 




















Figure 2.1. Overview of sera sample collection, preparation and analysis from sample 
collection to serum pooling as described in section 2.2.1. * CP denotes Control Pen, NP 























Figure 2.1 (continued). Overview of sera sample collection, preparation and analysis 
from Proteominer enrichment to Bioinformatic Analysis, as described in section 2.2.1. 








2.2.2 Protein Characterisation Methods 
2.2.2.1 Bradford Protein Assay 
Bradford reagent (Bio-Rad) was diluted 1 in 5 in PBS (Section 2.1.7.1) prior to use. 
Protein samples to be assayed was diluted appropriately, and the sample (20 μl) was 
added to diluted Bradford reagent (980 μl) followed by vortexing. The final sample (1 
ml) was then transferred to a plastic cuvette (1.5 ml) and incubated at room temperature 
for 5 min.  The absorbance (595 nm) was read using a spectrophotometer 
(BioPhotometer; Eppendorf) relative to an appropriate blank. Protein concentrations 
were then determined based on a standard curve (0.1 - 1.5mg/ml) 
2.2.3 ProteoMiner™ Serum Enrichment 
All pooled serum samples were first cleared of precipitate by centrifugation (5415 D; 
Eppendorf) (10,000 g 10 min). Serum samples (200 μl) were then applied to the 
Proteominer™ Protein Enrichment kit (163-3006; BioRad) according to manufacturer's 
instructions. ProteoMiner™ enrichment columns were first drained of storage solution 
by removing caps and placing columns in a capless collection tube and centrifuging 
(Minispin; Eppendorf) (1000 g, 1 min). Collected material was discarded. Columns 
were then washed by replacing caps and applying 200 μl wash buffer. Columns were 
rotated end-over-end several times for 5 min and then drained through centrifugation 
(1000 g, 1 min). This wash step was repeated twice. Precipitate-free serum samples 
(200 μl) were then applied to the washed ProteoMiner™ columns. Columns were rotated 
for 2 h at room temperature on a rotational shaker. Columns were drained of sera by 
removing caps and placing columns in a capless collection tube and centrifuging (1000 
g, 1 min). Columns were then washed by replacing caps and applying 200 μl wash 
buffer. Columns were again rotated end-over-end several times over 5 min and then 
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drained through centrifugation (1000 g, 1 min). This wash step was repeated twice. 
Deionised water (200 μl) was applied to columns which were rotated end-over-end for 1 
min and drained through centrifugation (1000 g, 1 min). 20 μl of either the provided 
ProteoMiner elution buffer or LCR (Section 2.1.2.5) was applied to the column. 
Columns were then lightly vortexed for 5 s over 15 min. Caps were removed and 
columns placed in capped collection tubes and centrifuged (1000 g, 1 min). This elution 
step was repeated twice giving 60 μl of enriched serum sample. Enriched serum samples 
were stored -20°C until further processing.  
2.2.4 Mass Spectrometry Methods 
2.2.4.1 Protein Digestion from Q-Exactive Liquid Chromatography - Mass 
Spectrometry (LC-MS/MS) analysis 
Enriched serum samples were removed from -20 °C and allowed to reach room 
temperature. Any precipitate was resuspended through light vortexing. Samples were 
tested for protein concentration by Bradford assay (Section 2.2.3.1). 10 μl of the 
enriched sample was then separated. Remaining samples were returned to -20°C 
storage. The pH of the sample was then adjusted to between 8.5 and 9.0 using 3 to 5 
volumes of Label-Free Solubilisation Buffer (Section 2.1.2.9). The volume of diluted 
enriched serum sample corresponding to 5 μg protein was then removed for further 
processing. Protein samples (5 μg each) were then brought to 10 mM DTT using 0.05 M 
DTT (Section 2.1.3.2) and incubated at 56°C for 30 min. Samples were then brought to 
25 mM IAA using 0.11 M IAA (Section 2.1.3.3). Lys-C (Section 2.1.3.4) (0.5 μl) was 
then added to samples at 1:100 ratio (Protease: Protein) and samples were incubated at 
37°C for 4 h. 50 mM Ammonium Bicarbonate (3 volumes) was then added to samples. 
Trypsin (Section 2.1.3.5) (0.8 μl) was then added to samples at 1:25 ratio (Protease: 
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Protein). Protease Max (Section 2.1.3.6) (0.45 μl) was then added. Samples were 
incubated at 37°C overnight. Using Sample Buffer (Section 2.1.2.10) (0.33 volumes) 
samples were then diluted. Peptide samples were evaporated to dryness in a 
SpeedyVac™ (DNA 120; Thermo Scientific) and stored at -20°C. 
2.2.4.2 ZipTip® Pipette Tip Protocol 
Peptide samples were resuspended in Resuspension buffer (20 μl) (Section 2.1.4.1) and 
sonicated for 2 min to aid peptide resuspension. Samples were then centrifuged briefly 
to collect peptide digests. ZipTips were wetted by aspirating and dispensing Wetting 
buffer (10 μl) (Section 2.1.4.2) into the tip using a pipette. This was repeated five times. 
The ZipTip was equilibrated by aspirating and dispensing Equilibration buffer (10 μl) 
(Section 2.1.4.3) into the tip using a pipette. This was repeated five times. Peptide 
samples were then individually applied to the ZipTips by aspirating and dispensing 
resuspended samples (10 μl) into the tip using a pipette. This was repeated fifteen times. 
The ZipTip bound peptide sample was then washed by aspirating Wash buffer (10 μl) 
(Section 2.1.4.4) into the tip and dispensing into a waste container, using a pipette. This 
was repeated five times. ZipTip bound peptides were then eluted by aspirating Elution 
buffer (10 μl) (Section 2.1.4.5) into the tip and dispensing into a clean Eppendorf tube, 
using a pipette. This was repeated five times. Eluted samples were evaporated to 
dryness in a SpeedyVac™ (DNA 120; Thermo Scientific) and stored at -20°C. On the 
day of analysis, samples were resuspended in Buffer A (20 μl) (Section 2.1.5.1). 
Samples were sonicated for 2 min to aid peptide resuspension. The samples were then 
centrifuged (minispin; Eppendorf) (13,400 rpm for 10 min). The peptide sample (15 μl) 




2.2.4.3 Q-Exactive: LC-MS/MS Analysis of Protein samples 
Peptide samples were analysed using a Thermo Scientific Q Exactive connected to a 
Dionex Ultimate 2000 (RSLnano) chromatography system. Each sample was loaded 
onto an EASY-Spray PepMap RSLC C18 column (75 μm x 500 mm), and separated by 
an increasing acetonitrile gradient over 120 min flow rate of 250 nl/min. The mass 
spectrometer was operated in positive mode with MS
n
 carried out on the 15 most 
abundant precursor ions at each time point. Singly charged ions were excluded from 
analysis. 
2.2.5 Bioinformatic Analysis  
2.2.5.1 Label-Free quantitative (LFQ) proteomic analysis using MaxQuant and 
Perseus 
Peptide-Spectral mapping and protein peptide matching of raw files from Q-Exactive 
analysis of LFQ proteomic analysis were carried out using MaxQuant (version 1.5.7.0; 
http://maxquant.org) (Tyanova et al., 2015). This utilised the Andromeda database 
search to match MS/MS data with the Gallus gallus 9031 reference proteome 
(UP000000539 - Gallus gallus) from UniProt (http://uniprot.org). Search parameters 
included: peptide tolerance (ppm) of 20 for first search and 4.5 for main search, 
carbidomethylation of cysteine as a fixed modification, oxidation of methionine and 
acetylation of N-termini as variable modifications, maximum 2 missed cleavage sites, 
and a minimum 1 peptide detected per protein. The maximum protein/ peptide false 
discovery rates were set at 1% based on a comparison to a reverse database (decoy 
database). The LFQ algorithm was used to generate normalised spectra intensities to 
infer relative protein abundance. 
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Subsequently, protein groups were exported and processed in Perseus (version 1.5.6.0; 
http://coxdocs.org/doku.php?id=:perseus:start) for data filtering (Tyanova et al., 2016). 
Proteins (i) only identified by site (ii) only identified by modification site, or (iii) 
identified by the decoy database were removed. Extracted LFQ intensities measured for 
each run were grouped according to treatment and time point. Protein abundances were 
log2 transformed. At each time point (Day 7, Day 21 and Day 35) treatment groups were 
compared to the control group creating three comparator groups (AP vs. Control, NS vs. 
Control and PT vs. Control). A 2-sample t-test was performed to identify proteins with 
significant (p < 0.05) within each comparator group. Proteins uniquely detected in a 
treatment group and absent from control or proteins absent from treatment and present 
in control groups were identified and tabulated. 
Pathway mapping was carried out using Reactome Pathway Database 
(https://reactome.org/). Proteins were specifically analysed for features and/or functions 
in UniProt (http://uniprot.org). 
2.2.5.2 Software Graphing and Statistical Analysis 
All statistical analyses and graphing was carried out using GraphPad Prism (version 5.0; 

























Proteins possess tremendous importance in the analysis of the status of living organisms 
as they are direct biofunctional molecules and changes in protein abundance can be 
indicators of an animal's wellbeing (Zhang et al., 2013). Consequently, the 
identification and quantification of changes in protein concentration is an effective 
means of investigating the health and disease status of subjects.  
 With very little previous information about avian serum proteomics available in 
the literature, see Table 1.1, there is currently no established protocol for this type of 
proteomic analysis. Therefore, the development of a protocol for the pre-fractionation 
and preparation of serum for LC-MS/MS analysis was required before quantitative 
proteomics could be conducted on trial samples. 
 Serum pre-fractionation is a necessary step in proteomic analysis due to the 
disparity between the dynamic range of serum protein concentrations, which is over 10-
12 orders of magnitude (Issaq et al., 2007), and the dynamic range of detection of 
current MS-based technologies (4-5 orders of magnitude) (Makarov et al., 2006). This 
disparity can lead to poor identification of low abundance proteins which reduces the 
depth of analysis. Reduction in the concentration of a number of high abundance 
proteins (HAP) is a key step in reducing dynamic range of serum protein concentration 
and should allow greater visibility of the low abundance proteome (Doucette et al., 
2011). Selective immunodepletion of these HAP is often the method of choice in 
proteomic analysis of serum from heavily studied organisms such as human or mouse 
(Echan et al., 2005; Haudenschild et al., 2014). However, this technology has not yet 
been developed for livestock serum and so was not initially an option for the pre-
fractionation of broiler serum samples (Di Girolamo et al., 2014; Henning et al., 2015).  
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Proteominer™ is a saturation based, enrichment technology that narrows the dynamic 
range of applied proteomes and facilitates identification and quantification of low 
abundance proteins (LAP) which would otherwise be undetectable. Randomly 
generated, equimolar, hexapeptide ligands allow species-independent LAP enrichment, 
which represents a valuable alternative to immunodepletion techniques (Millioni et al., 
2011). This technology has the added benefit of being non-depleting, meaning that HAP 
are not selectively depleted, this reduces the risk of co-depletion or non-specific 
depletion of proteins of interest (Righetti & Boschetti, 2007; Marco-Ramell & Bassols, 
2010; Di Girolamo et al., 2014). Due to these advantages, Proteominer™ technology 
was selected as the pre-fractionation technique to be used in the quantitative proteomic 
analysis of the effects of Alltech feed products on broilers. 
 The commercial elution buffer provided within the Proteominer™ kit contains 3-
[(3-Cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), a detergent 
used to solubilise proteins and ensure elution from the enrichment column. Detergents 
can not only cause ion suppression during MS analysis (Yeung et al., 2008) but also 
have deleterious effects on C18 columns (Deschamps, 1986) which are used for protein 
separation in LC-MS/MS analysis. Therefore, to ensure maximum protein identification 
as well as column integrity, it proved necessary to alter a reagent used in protein elution 
from Proteominer™ columns. 
 The overall objective of the work presented in this Chapter was to develop and 







3.2.1 Preliminary proteomic analysis of broiler serum 
Twelve serum samples were used in preliminary proteomic analysis. These serum 
samples were from individual broiler chickens harvested on Day 35, three serum 
samples from each treatment group. Serum samples were enriched for LAP using 
Proteominer™ enrichment technology. Enriched serum samples were then analysed 
through LC-MS/MS. Figure 3.1 shows a frequency distribution graph of the number of 
proteins and sequence coverage of proteins detected across the serum samples (n = 12) 
prepared using the commercial Proteominer™ buffer. A total of 380 proteins were 
detected across samples applied to the LC-MS/MS in preliminary analysis. Of detected 





















Figure 3.1 Frequency distribution graph of samples prepared using the commercial 













 Figure 3.2 shows a total ion chromatogram of a serum sample prepared using the 
commercial Proteominer™ elution buffer. Detection levels are low throughout this LC-
MS/MS analytical run until 125 min, when a large peak can be seen. The m/z for this 
peak is 615.4. This m/z corresponds to CHAPS, a component of the commercial 
Proteominer™ elution buffer. This large CHAPS peak (125 min-130 min)(Blue Arrow) 
caused suppression in peptide detection within the enriched serum sample. The base 
peak of this chromatogram is 1.39E10.  
 
 
Figure 3.2 Total Ion Chromatograph of one representative sample prepared using the 










3.2.2 Development and analysis of LC-MS/MS Compatible Reagent (LCR) 
In order to avoid the signal suppression effect seen in proteomic samples prepared using 
the commercial Proteominer™ elution buffer, an alternative reagent was developed, 
lacking CHAPS but capable of eluting proteins from the enrichment column. This 
buffer, LCR (Section 2.1.2.5), was used in place of the commercial Proteominer™ 
elution buffer during protein enrichment. One serum sample was enriched for LAP 
using the Proteominer™ technology with LCR used in place of the commercial elution 
buffer. The enriched serum sample was then analysed by LC-MS/MS. Figure 3.3 shows 
a total ion chromatogram of the serum sample prepared using LCR This total ion 
chromatogram lacks the large peak between 125 min and 130 min that was previously 
seen in samples prepared using the commercial Proteominer™ elution buffer (Figure 
3.2). Higher levels of peptide detection can be seen throughout this LC-MS/MS analysis 










 The number of proteins detected and sequence coverage of detected proteins 
were compared between data obtained from analyses done on a serum sample prepared 
using the commercial Proteominer™ elution buffer and the same serum sample 
prepared using LCR. It can be seen in Figure 3.4 that a greater number of proteins were 
detected and higher sequence coverage was achieved using LCR whereby 218 proteins 
were detected in the serum sample prepared using the commercial Proteominer™ 








Figure 3.4 Cumulative frequency distribution graph comparing proteins detected in 









 Proteins (n =218) were identified in the serum sample prepared using the 
commercial Proteominer™ buffer (Figure 3.5). However, 475 proteins were detected in 
the serum sample prepared using LCR. Of these proteins, 196 were identified by both 
analyses. Proteins (n = 22) were uniquely identified in the sample prepared using the 
Proteominer™ elution buffer and 279 proteins (over 10-fold more) were uniquely 










Figure 3.5 Venn Diagram comparing proteins identified during LC-MS/MS analyses of 







3.2.3 Comparison of sample groups prepared using Proteominer Elution Buffer 
and LCR 
In order to further evaluate the effects of the replacement elution buffer on larger 
sample groups, twelve serum samples prepared using the Proteominer elution buffer 
were compared to twelve serum samples prepared using LCR. Samples prepared using 
the commercial Proteominer™ buffer are from three individual birds obtained from 
each feed group on Day 35. Samples prepared using LCR are serum samples pooled by 
pen on Day 35. All serum samples were enriched for low abundance proteins using the 
Proteominer™ small-capacity enrichment kit and analysed through LC-MS/MS. It can 
be seen in Figure 3.6 that a greater number of proteins were detected and higher 
sequence coverage was achieved using the LCR reagent. There was a 55% increase in 
the total number of proteins identified and an 88% increase in the number of proteins 
identified with greater than 10% sequence coverage in samples prepared using LCR, 

















Figure 3.6 Cumulative frequency distribution graph comparing proteins detected in 














Proteominer technology is pre-fractionation technique used to enrich proteomic samples 
for LAP and increase the numbers of identified proteins. This technology was 
developed for use with 2D-PAGE and contains CHAPS, a detergent in the elution 
buffer responsible for ensuring the elution of proteins from the enrichment column. 
However, detergents can cause signal suppression in MS analysis and have a deleterious 
effect on C18 chromatography columns (Deschamps, 1986; Yeung et al., 2008). This 
signal suppression is evident in Figure 3.2, a representative total ion chromatogram of 
one sample prepared for LC-MS/MS using the commercial Proteominer™ elution 
buffer. A large peak corresponding to CHAPS can be seen between 125 min and 
130min in this chromatogram. This large peak represents the high concentration of 
CHAPS present in the peptide sample which caused signal suppression resulting poor 
ion detection throughout the analytical run. The result of this poor ion detection is 
evident in Figure 3.1. The total number of proteins identified was relatively low and 
35% of these proteins were identified with less than 10% sequence coverage.  
 In order to prevent signal suppression and abolish any chance of column 
deterioration during LC-MS/MS analysis, it was essential that CHAPS be excluded 
from sample preparation. In order to exclude CHAPS from peptide samples and also 
ensure elution of proteins from the Proteominer™ column, an alternative reagent was 
developed. LCR, lacks detergent and contains high concentrations of Urea (6M) and 
Thiourea (2M) which solubilise and denature proteins and cause dissociation from 
hexapeptide ligands leading to the elution of proteins from the enrichment column.  
 The removal of CHAPS from the elution buffer allowed greater ion detection 
throughout LC-MS/MS analytical runs. It can be seen from Figure 3.3 that the large 
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peak, corresponding to CHAPS, which is visible in Figure 3.2, has been removed with 
the change in elution buffer. Improved ion detection can be seen throughout this 
analysis. 
 Base peak intensity is the intensity of the most abundant ion in a total ion 
chromatogram obtained during MS. This peak is used to scale the chromatogram and is 
assigned a relative abundance value of 100 (Price, 1991). When comparing Figure 3.2 
and Figure 3.3, it can be seen that the base peak intensity, visible in the top right of the 
chromatogram, is similar in both chromatograms, 1.39E10 and 1.30E10 respectively. 
Thus, the increase in ion intensity visible in Figure 3.3 is due to an increase in ion 
detection and not due to scaling differences in the chromatograms.  
 The effect of this increase in detection can be seen in Figure 3.4. This 
cumulative frequency distribution graph demonstrates a considerable improvement in 
protein identification. Figure 3.4 shows the effects of the change in elution buffer on 
one serum sample prepared using the Proteominer™ elution buffer and LCR. A 
dramatic increase in the total number of proteins identified can be seen. The number of 
proteins detected increased from 218 to 475 proteins. The number of proteins detected 
with greater than 10% sequence coverage also increased from 169 to 339 with the 
change in elution reagent. This higher level of protein identification allows greater 
information to be obtained on the serum proteomic content of the source animal. 
 Figure 3.5 shows a comparison between proteins detected using the commercial 
Proteominer™ elution buffer and LCR. A total of 218 proteins were identified in the 
peptide sample prepared for LC-MS/MS analysis using the commercial Proteominer™ 
buffer. Proteins (n = 475) were identified in samples prepared using LCR. Proteins (n 
=196) were identified in both LC-MS/MS analyses with 179 proteins uniquely 
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identified using the newly developed LCR. Proteins (n = 22) that were detected in the 
peptide sample prepared using the provide Proteominer™ buffer, were not detected 
using in samples prepared using LCR. Though this small number of undetected proteins 
could represent potential protein identification loss with the newly developed elution 
buffer, the gain in total protein identification number as well as the removal of risk of 
any deleterious effect on the C18 chromatography column compensates for this 
potential shortcoming. 
 In comparison of samples prepared using LCR and those prepared using the 
commercial Proteominer™ buffer, it can be seen in Figure 3.6 that the implementation 
of LCR led to improved protein detection. Though these samples differ slightly in their 
preparation, one set from individual birds and one set consisting of pooled sera, the 
capability of LCR to improve protein identification is evident from this analysis. With 
the implementation of LCR there was an improvement in protein detection, with 55% 
more proteins identified in samples prepared using LCR. There was also an 
improvement in percentage sequence coverage. Proteins (35%) detected in samples 
prepared using the commercial Proteominer™ elution buffer were identified with less 
than 10% sequence coverage. This number was reduced to 25% in samples prepared 
using LCR which translated to an 88% increase in the total number of proteins detected 
with greater than 10% sequence coverage. This improved sequence coverage allows 
greater confidence in proteins that have been identified.  
 In comparison to previous studies completed on serum samples prepared using 
the Proteominer™ enrichment technology, the implementation of LCR proved effective. 
Many of the previous studies which employed Proteominer™ technology for the 
enrichment of serum/plasma proteins used in-gel techniques such as 2D-PAGE or 
differential in gel electrophoresis (DIGE) followed by analysis through an MS 
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technology (Cumová et al., 2012; González-Iglesias et al., 2014; Righetti et al., 2014; 
de Seny et al., 2016; de Jesus et al., 2017), therefore are not suitable for the direct 
comparison of protein detection capabilities. A number of previous studies which have 
used Proteominer™ with LC-MS/MS employed several methods so that the enriched 
protein sample is eligible for LC-MS/MS analysis. In a recent study, Pisanu et al. 
(2018) implemented a reagent change, whereby the Proteominer™ elution buffer was 
substituted with 100 mM Tris-HCl, 0.8% SDS, pH 6.8. The elution procedure was more 
laborious with 1 h wash steps used instead of the 15 min wash steps recommended by 
the manufacturer. This change in elution reagent allowed the detection of 553 proteins 
from a single serum sample. The number of proteins detected in this serum sample was 
16% higher than the number of proteins detected in a single serum sample prepared 
using LCR (n = 475). This improvement in protein detection could be an indication of a 
more effective enrichment step. However, the use of SDS in the elution buffer 
necessitated the introduction of a filter aided sample preparation (FASP) step which 
could, in larger sample sets, introduce significant variability. SDS can, if not completely 
removed from proteomic samples, also have deleterious effects on C18 columns and 
introduce signal suppression effects (Rundlett & Armstrong, 1996; Botelho et al., 2010) 
which could further adversely affect the reproducibility of results using this method. 
Another approach that was taken in previous Proteominer™ LC-MS/MS studies was the 
precipitation of proteins from the commercial elution buffer prior to LC-MS/MS 
analysis. Millioni et al. (2011) precipitated proteins from the elution buffer using 
acetone, followed by strong cation exchange fractionation of tryptic peptides. This 
method allowed the detection of 318 proteins in a single serum sample. Another study 
conducted by Capriotti et al. (2012) precipitated proteins from the elution buffer using 
chloroform and methanol. The number of proteins detected across 3 technical replicates 
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were 238 proteins, 240 proteins and 250 proteins, respectively. The average number of 
proteins detected in one serum sample using this method was 243. Although these 
precipitation methods did allow LC-MS/MS analysis of the enriched serum proteins, 
they did not allow the same level of protein identification that was achieved in the 
present study and the addition of a precipitation step could reduce reproducibility in 
larger sample groups. With relatively high protein identification capabilities and without 
the need for further downstream steps prior to protein digestion, elution of proteins from 
the Proteominer™ column using LCR is therefore a valuable alternative to the methods 
used previously with Proteominer technology to prepare serum samples for LC-MS/MS 
analysis. 
 In conclusion, in order to achieve maximum identification of serum proteins and 
avoid issues with LC-MS/MS signal suppression, it was essential to develop an 
alternative elution reagent for the Proteominer™ enrichment kit. This new elution 
buffer allowed greater peptide detection which resulted in a larger number of serum 
proteins detected with higher sequence coverage, and should allow greater access to the 
serum proteome, giving a more in-depth view into the effects of feed treatments. In 
comparison to previous studies including application of Proteominer™ enriched serum 
samples to the LC-MS/MS, the induction of the new reagent proved effective and 
without the need for precipitation or FASP step prior to LC-MS/MS, could improve the 
reproducibility of sample preparation. The reagent may also have applications for the 
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With the introduction of bans on the use of antibiotic growth promoters (AGP) in 
animal husbandry, interest in alternative growth promoters has grown immensely. Yeast 
and its derivatives, such as yeast cell wall (YCW), have emerged as valuable 
alternatives to AGP and have been shown to impart a number of beneficial effects on 
the animal which have application in the field of animal husbandry. Some noted effects 
of yeast-based products include modulation of the gut microbiome (Yang et al., 2009) 
reduced infection by pathogenic bacteria and beneficial stimulation of the host immune 
system (Gao et al., 2003; Chae et al., 2006; Goodridge et al., 2009; Dalonso et al., 
2015; Song et al., 2014; Hoving et al., 2018). The effects of yeast and its derivatives has 
been widely studied (Brown, 2006; Kogan & Kocher, 2007; Song et al., 2014)  but the 
literature available for serum proteomic analysis of these effects is limited. With recent 
advances in serum proteomics, this area now represents an exciting opportunity to 
investigate the biological effects of YCW feed supplementation in broiler chickens. 
 Immunological responses triggered by the YCW are largely due to the action of 
two molecules, Mannose Oligosaccharide (MOS) and β-glucan. These molecules are 
highly abundant in YCW and modulate the immune system of the host through the 
binding of receptors which are expressed on the surface of macrophages and monocytes 
as well as in the serum of the host eliciting downstream immunological stimulation 
(Kogan & Kocher, 2007; Song et al., 2014).β-glucan is bound by Complement receptor 
type 3 (Ross et al., 1987), lactosylceramide (Zimmerman et al., 1998), and Dectin-1 
(Brown, 2006) as well as a number of scavenger receptors present in monocytes (Rice et 
al., 2002). MOS is bound by the Mannose receptor which is a c-type lectin receptor 
(Gazi & Martinez-Pomares, 2009) capable of recognising self and mannan ligands and 
is present on the surface of macrophage and endothelial cells (Ringo et al., 2010; Ringo 
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et al., 2014). Mannan ligands may also bind other receptors such as DC-SIGN and 
Dectin-2 which can elicit immunological responses such as leukocyte activation (Gazi 
& Martinez-Pomares, 2009).  
 YCW immunostimulation has been reported in a number of species including 
human (Rice et al., 2002), fish (Song et al., 2014) and mice (Majtán et al., 1998) as well 
as livestock such as cows (Kimura et al., 2008), pigs (Xiao et al., 2004; Kogan & 
Kocher, 2007) and broiler chickens (Gao et al., 2003) and has been shown to induce a 
range of immunological effects both in vivo and in vitro. Previous in vitro studies have 
shown that the binding of these receptors by fungal glycan ligands can lead to 
immunological responses such as enhancing the functional status of macrophages and 
neutrophils (Williams et al., 1996; Tzianabos, 2000; Zeković et al., 2005), release of 
TNF-α from macrophages (Majtán et al., 1998; Engstad et al., 2002; Gantner et al., 
2003; Brown, 2006) cytokine and chemokine production in macrophages (Adachi et al., 
1994; Olson et al., 1996; Young et al., 2001; Gantner et al., 2003; Brown, 2006) and 
enhancing TNF-γ response in T-cells (Xiao et al., 2004). The ability of epithelial cells 
to secrete macrophage inflammatory protein was also increased with the administration 
of β-glucan (Hahn et al., 2003). PGG-glucan, another carbohydrate-based prebiotic was 
seen to increase the migration of neutrophils towards C5a (Tsikitis et al., 2004). 
 In vivo immunological effects have also been reported. Addition of glycan 
ligands to the feed of animals has been shown to elicit immunological responses such as 
increased resistance to bacterial and parasitic infection in mice (Yun et al., 1997; Yun et 
al., 1998; Yun et al., 2003; Kournikakis et al., 2003). With the addition of glucan 
phosphate, another carbohydrate prebiotic, to the diet, an increased resistance to 
Staphylococcus aureus and Candida albicans was observed (Rice et al., 2005). The 
ability of immature chickens to fight Salmonella enterica serovar Enteritidis was 
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increased with the addition of β-glucan to the diet (Lowry et al., 2005), which was 
accompanied by increased phagocytic activity in heterophils and increased oxidative 
burst. An increase in LPS-induced TNF-α and IL-6 production was detected in the 
blood of weaned pigs with dietary β-glucan supplementation (Bohn & BeMiller, 1995). 
 The complement system is a non-cell mediated innate immune response which is 
present in the serum of the host. This response is mediated either through the binding of 
antigen-specific antibodies, direct binding of microbial cell surfaces or  lectin-specific 
binding of carbohydrate residues (Levitz, 2010) and is shown in Figure 4.1. 
Complement activation leads to cleavage of proteolytic precursors to form complement 
components (Abbas et al., 2017) which can be measured as increased serum titre of 









Figure 4.1. Graphical representation of complement activation pathways and assembly 




Fungal components are potent activators of the complement which leads to opsonisation 
and recruitment of inflammatory cells as a result of C3a and C5a generation. Fungal 
stimulation of the complement cascade can be activated through the classical, 
alternative or lectin pathways (Levitz, 2010). Although the effects of YCW feed 
supplementation on the complement has not been reported specifically in broiler 
chickens, as far as could be found in the literature, it has been previously seen that MOS 
and β-glucan can activate the complement cascade (Dlabač & Kawasaki, 1994; Bohn & 
BeMiller, 1995; Levitz, 2010; Song et al., 2014) and the absorption of β-glucans into 
the circulatory system and their presence in the serum has been previously shown in 
mice (Rice et al., 2005) which would allow for complement stimulation.  
 Selenium is an essential dietary mineral in poultry nutrition with vital roles in 
the detoxification of reactive oxygen species (ROS), immune function and productivity 
(Surai, 2002; Surai & Fisinin, 2014). Sources of selenium in the diet of poultry include 
inorganic selenium, such as selenite or selenate, or organic yeast-derived selenium 
which has the mineral incorporated into proteins and peptides in the form of 
selenomethionine (SeMet) or selenocysteine (SeCys) (Peric et al., 2009). Organic 
selenium is taken up in the gastrointestinal tract of animals through the amino acid 
transport mechanism (Surai, 2002) and is reportedly more bioavailable than its 
inorganic forms (Rayman, 2004; Lönnerdal et al., 2017). Inorganic selenium can also be 
seen to have pro-oxidative effects and can contribute to oxidative damage (Peric et al., 
2009).  
In the last number of decades, consumer awareness of meat quality has dramatically 
improved. Water lost during meat preparation and cooking is referred to as drip-loss and 
has become synonymous with poor quality meat and for that reason should be mitigated 
(Northcutt et al., 1994). Drip-loss has been linked to oxidative damage of cell 
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membranes which allows seepage of cellular contents (Mahan et al., 1999). 
Antioxidants, such as the Se-dependant Glutathione Peroxidase (GSH-Px), have been 
previously linked with a reduction in drip-loss and improved poultry meat quality 
(Choct et al., 2004). Selenium forms a vital part of GSH-Px (Arthur et al., 1992) and 
dietary supplementation has been previously seen to increase the level of GSH-Px in the 
serum (Wang & Xu, 2008; Jiang et al., 2009; Pappas et al., 2005; Wang et al., 2011; 
Cai et al., 2012; Yoon et al., 2007) and muscle (Pappas et al., 2005; Wang et al., 2011; 
Zhou & Wang, 2011; Cai et al., 2012) of chickens. Increased levels of selenium in the 
serum and muscle of the broiler chicken are not only of protective benefit to the chicken 
but also of benefit to the consumer, as it has been found that the intake of selenium in 
most Europeans’ diet is below recommended values and that selenium-enriched foods 
are a helpful supplement in maintaining selenium levels (Thiry et al., 2013). The 
selenium source included in the control, Natustat® (NS) and Actigen®-Pak (AP) diets 
was inorganic selenite/selenate. PowerTract® (PT)-supplemented broilers were fed an 
organic selenium yeast source as part of the feed supplement.  
 Essential oils (EO) are another feed additive used in feed animal 
supplementation (Windisch et al., 2008; Gong et al., 2014; Zou et al., 2016). These 
products have been shown to elicit effects such as enhancing total antioxidant capacity 
(Zeng et al., 2015), immunostimulation (Zeng et al., 2015) and antimicrobial activity 
(Rota et al., 2007) all of which can beneficially contribute to the health and immune 
status of the animal. The YCW supplement Natustat® used in this study contains EO. 
 The blood of an animal is an excellent reservoir of biomarkers of health and 
disease. This biofluid flows through the entire body of the animal so can offer 
exceptional insights into internal biological activity. Serum, a blood derivative lacking 
cells as well as clotting factors, is an excellent indicator of health and immune status 
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(Issaq et al., 2007; Biosa et al., 2011) and may offer a potential insight into how these 
YCW products are affecting the broiler chicken. Using Liquid Chromatography-tandem 
mass spectrometry (LC-MS/MS) analysis and with the implementation of LC-MS/MS 
Compatible Reagent (LCR) in sample preparation, the effects of three YCW-based feed 
supplements, AP, NS and PT on the health status of the broiler chicken was 
investigated. These three feed supplements are yeast-derivative based with some 
supplementation. NS is supplemented with essential oils and PT contains an organic 
selenium source. For each treatment group, proteins that were significantly different in 
abundance (p < 0.05) in comparison to control group, as well as proteins that were 
uniquely identified or absent in serum samples from supplemented birds, when 
compared to control, were tabulated and analysed. No cut-off value was applied to fold 
changes.  
The objectives of the work presented in this chapter were: 
i.  Through serum proteomics, examine the effects of YCW feed on broiler 
chickens, through comparison with a control basal feed. 











4.2.1 Overview of LC-MS/MS results  
Tryptic digests, from 36 pooled serum samples, were analysed by LC-MS/MS across 
three time points, Day 7, Day 21 and Day 35. Within each time point, each treatment 
group was compared to control which created three comparator groups: AP vs. control, 
NS vs. control and PT vs. control, for each time point. Within each comparator group, 
proteins which were significantly changed in abundance (p < 0.05) as well as proteins 
which were uniquely present in treatment groups in comparison to the control group or 
uniquely absent in treatment groups versus control, were tabulated and analysed. 
Between 5% and 12% of the total identified proteins within each comparator group 
showed changes in abundance (Table 4.1). The largest change in protein abundance was 
seen on Day 7, with an average of 9.11% of proteins changed in abundance or unique 
to/absent from the serum of treated birds when compared to control birds. NS-treated 
birds showed the largest change in protein abundance throughout the three time points 
with an average of 7.78% of proteins changed in abundance. The largest individual 
change in abundance was seen in Day 7 NS vs. control samples with 11.06% of proteins 
changed.  
 Inter-day and inter-treatment analysis were also conducted on the total proteins 
identified throughout all serum samples analysed. This was achieved by applying LC-
MS/MS data obtained from each sample to the data analysis software MaxQuant (MQ), 
first grouped by Day and then, in a separate analysis by treatment. Proteins (n = 1007) 
were identified in at least one serum sample from all time points (Figure 4.2). The 
majority of proteins (n = 512) (51% of total proteins) were shared between at least two 
time points. Proteins (n = 169) were uniquely identified in pooled serum samples 
obtained on Day 7, on Day 21 (n = 117) and on Day 35 (n = 209). Proteins (n = 602) 
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were identified in at least one serum sample from all treatment groups (Figure 4.3). The 
majority of proteins (n = 733) (74% of total proteins) were shared between at least two 
treatment groups. Proteins (n = 27) were uniquely identified in pooled serum samples 
from the control treatment group, in the AP treatment group (n = 22), in the NS 
treatment group (n = 51) and the PT treatment group (n = 150).  
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Table 4.1. Overview of proteins with significantly changed abundance within comparator groups.  
Comparator Group Total Identified Proteins Significant Changes* Unique / Absent Changes** Total Changes Total Changes (%) 
D7 AP vs. control* 
651 
38 26 64 9.83 
D7 NS vs. control 51 21 72 11.06 
D7 PT vs. control 14 28 42 6.45 
D21 AP vs. control 
588 
25 9 34 5.78 
D21 NS vs. control 34 9 43 7.31 
D21 PT vs. control 23 10 33 5.61 
D35 AP vs. control 
624  
21 17 38 6.09 
D35 NS vs. control 21 10 31 4.97 
D35 PT vs. control 29 14 43 6.89 
* Significant changes denotes proteins which have changed in abundance with p < 0.05 in a two-sample t-test 













































4.3 Quantitative proteomic analysis of serum from broilers fed an Actigen®-
Pak supplemented diet vs. serum from broilers fed a control diet 
A total of eighty-two proteins were found to be significantly increased in abundance (p 
<0.05) or uniquely present in AP samples with comparison to control (Table 4.2). 
Proteins (n =55) were found to be significantly decreased (p <0.05) in abundance or 
absent in serum of AP samples (Table 4.3).  
 Principal component analysis (PCA) was conducted on proteomic data obtained 
from LC-MS/MS analysis of AP and control serum samples (Figure 4.4). These data 
show that AP samples and control samples cluster separately on Day 7, Day 21 and Day 
35. Hierarchal clustering was also conducted on proteomic data which matched PCA 
results on Day 7, Day 21 and Day 35 (data not shown).  
 Nineteen proteins, characterised to be involved in the innate immune system by 
Reactome pathway mapping software, were significantly increased (p  <0.05) in 
abundance in the AP serum samples: namely Proteasome subunit beta 1 
(A0A1L1RYR5),  Chromogranin A (F1NLZ2), Proteasome 26S subunit, ATPase 5 
(F1NU79), Uncharacterized protein (Q5F491), Surfactant protein A (Q90XB2), 
Pantetheinase precursor (E1BUA6), Uncharacterized protein (F1NPN5), Alpha-1,4 
glucan phosphorylase (E1BSN7), Uncharacterized protein (A0A1D5PW77), T-complex 
protein 1 subunit theta (F1NEF2), Proteasome subunit beta type  (A0A1L1RUE7), 
Transthyretin (P27731), Elongation factor 1-alpha 1 (Q90835), Proteasome subunit 
alpha type (F1NEQ6), Metalloproteinase inhibitor 2 (R4GIL5), Cathepsin D (Q05744), 
Complement C4 Precursor (A0A1D5P5V5), Complement C6 (B8ZX71) and 
Complement C7 (E1C6U2). These are represented in a Reactome pathway map (Figure 
4.5). Mannose-binding protein (Q98TA4) was increased in abundance and approaching 
significance (p = 0.2) on Day 35 in AP samples. 
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 A number of proteins involved in carbohydrate metabolism were also 
significantly increased in abundance in AP samples, specifically Glyceraldehyde-3-
phosphate dehydrogenase (P00356) and phosphoglycerate Kinase (F1NU17) were 
significantly increased (p < 0.05) in AP samples on Day 7.  
 Individual proteins of note also showed changes in abundance in AP samples. 
Osteocalcin (P02822), a marker for bone resorption, was uniquely identified on Day 21. 
Gastrokine-2 (A0A1D5PFM9) is uniquely present in the serum of AP treated birds on 
Day 35. Insulin-like growth factor II was significantly decreased (p <0.05) in abundance 
on Day 35. Transferrin receptor protein 1 (F1NTM6) was increased in abundance and 
approaching significance (p = 0.06) (Appendix 1-Table 7.1) on Day 35.  
 Proteins (n = 3) involved in vitamin A transport (Zabetian-Targhi et al., 2015; 
Hu et al., 2017) were increased in abundance in AP samples. Transthyretin (P27731) 
was significantly increased in abundance on Day 35, Retinol binding protein 7 
(E1C0M1) was uniquely present on Day 7 and Retinol-binding protein 4 (P41263) was 
increased in abundance and approaching significance (p = 0.08) on Day 21(Appendix 1-
Table 7.1). 
 A number of proteins involved in nucleotide metabolism were significantly 
altered in abundance (p < 0.05) in AP samples. These were 3'-phosphoadenosine 5'-
phosphosulfate synthase 1 (E1C8P2) which was uniquely present and Adenylate kinase 
isoenzyme 1 (P05081) that was significantly increased (p < 0.05) on Day 7. Nucleoside 
diphosphate kinase (O57535) was uniquely present on Day 35 whereas Adenosine 
Deaminase (A0A1D5PDK4) was significantly decreased in abundance (p <0.05) on 
Day 35.  
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Finally, Alpha-1-Acid Glycoprotein was increased in abundance on Day 35 in samples 
from AP supplemented birds with a large fold change (Appendix 1-Table 7.2). 


















INSERT A. B. and C. 
Figure 4.4. Principal Component Analysis (PCA) comparing AP serum samples (Red) 











Table 4.2.  Proteins with significantly (p < 0.05) increased abundance or unique in AP treatment samples. Proteins are listed in order of 
change of abundance. 
Protein Description Fold change
1





Barrier to autointegration factor 1 Unique 2 42.2 Day 7 A0A1D5NXY4 
Uncharacterized protein Unique 2 1.0 Day 7 A0A1D5NZ61 
Dynactin subunit 2 Unique 6 22.1 Day 7 A0A1D5PGQ9 
Legumain Unique 2 11.8 Day 7 A0A1L1RX51 
Proteasome subunit beta 1 Unique 3 36.4 Day 7 A0A1L1RYR5 
Retinol binding protein 7 Unique 3 32.1 Day 7 E1C0M1 
Ankyrin repeat domain 2 Unique 2 8.9 Day 7 E1C1Q6 
Mediator of cell motility 1 Unique 3 21.9 Day 7 E1C6C0 
3'-phosphoadenosine 5'-phosphosulfate synthase 
1 
Unique 5 12.3 Day 7 E1C8P2 
Uncharacterized protein Unique 4 30.8 Day 7 F1N8Y3 
Elongation factor 1-alpha Unique 15 49.9 Day 7 F1N9H4 
Succinyl-CoA:3-ketoacid-coenzyme A 
transferase  
Unique 3 11.0 Day 7 F1N9Z7 
Four and a half LIM domains 1 Unique 4 18.5 Day 7 F1NED9 




Protein Description Fold change
1





Small nuclear ribonucleoprotein 13 Unique 3 30.5 Day 7 F1NII6 
Chromogranin A Unique 2 10.7 Day 7 F1NLZ2 
PDZ and LIM domain 5 Unique 4 8.2 Day 7 F1NTC8 
Proteasome 26S subunit, ATPase 5 Unique 3 12.7 Day 7 F1NU79 
Cofilin-2  Unique 3 25.9 Day 7 P21566 
Uncharacterized protein Unique 2 3.7 Day 7 Q5F491 
Profilin Unique 2 27.9 Day 7 Q5ZL50 
Endophilin-A2  Unique 4 20.4 Day 7 Q8AXV0 
Surfactant protein A Unique 3 16.2 Day 7 Q90XB2 
Seryl-tRNA synthetase Unique 2 4.3 Day 7 R4GJ59 
Disintegrin and metalloproteinase domain-
containing protein 33 precursor 
Unique 2 3.6 Day 21 A0A1D5NV10 
Calpastatin Unique 2 3.9 Day 21 A0A1D5PFJ2 
Tubulointerstitial nephritis antigen like 1 Unique 2 10 Day 21 F1N8G6 






Protein Description Fold change
1





Tenascin  Unique 8 8.7 Day 21 P10039 
Tenascin  Unique 10 10.8 Day 35 P10039 
Gastrokine-2 Unique 2 18.6 Day 35 A0A1D5PFM9 
N-acetylglucosamine-1-phosphate transferase 
gamma subunit 
Unique 2 16 Day 35 E1BS68 
Pantetheinase precursor Unique 10 27 Day 35 E1BUA6 
Adhesion G protein-coupled receptor G6 Unique 2 2.5 Day 35 E1C8C2 
Alpha-1-anti-ase Unique 9 27.8 Day 35 F1NPN5 
Nucleoside diphosphate kinase  Unique 3 28.1 Day 35 O57535 
Apolipoprotein B (Fragment) Unique 7 24.7 Day 35 P11682 
Glycerol-3-phosphate dehydrogenase 1.55 9 37.5 Day 7 A0A1D5P1Y7 
Adenylate kinase isoenzyme 1  1.44 11 63.4 Day 7 P05081 
Glyceraldehyde-3-phosphate dehydrogenase  1.33 20 75.1 Day 7 P00356 
Myosin regulatory light chain 2, skeletal muscle 
isoform  
1.22 9 64.3 Day 7 P02609 
Heat shock protein beta-1 1.15 18 79.4 Day 7 F1P593 












Phosphoglycerate kinase 1.07 17 60.9 Day 7 F1NU17 
Proline and arginine rich end leucine rich repeat 
protein 
1 10 32.9 Day 7 A0A1D5PAN0 
Uncharacterized protein 0.97 7 25.5 Day 7 F1NIP5 
Protein/nucleic acid deglycase DJ-1 0.91 5 59 Day 7 A0A1D5PN39 
Actin, alpha skeletal muscle 0.89 13 24.4 Day 21 A0A1I7Q414 
Uncharacterized protein 0.84 2 3.7 Day 21 F1NMN2 
Carbonic anhydrase 2  0.83 7 44.6 Day 35 P07630 
Alpha-1,4 glucan phosphorylase  0.81 5 7.8 Day 35 E1BSN7 
Uncharacterized protein 0.8 54 24 Day 21 A0A1D5PW77 
Receptor of-activated protein C kinase 1 0.75 9 56.9 Day 7 A0A1I7Q3Y2 
Complement C7 0.73 28 54.3 Day 35 E1C6U2 
Low molecular weight phosphotyrosine protein 
phosphatase 
0.69 10 60.8 Day 7 A0A1D5P9Z1 
Uncharacterized protein 0.69 7 24.1 Day 7 A0A1L1RQM3 
T-complex protein 1 subunit theta 0.65 8 21 Day 7 F1NEF2 












Transthyretin  0.64 9 72.7 Day 35 P27731 
Cystatin A 0.62 4 18.3 Day 21 F1NHG8 
Tropomyosin alpha-1 chain 0.61 16 57.2 Day 7 A0A1D5NVL7 
Serpin H1  0.58 12 44 Day 7 P13731 
60 kDa heat shock protein  0.57 12 34.4 Day 7 Q5ZL72 
Complement C6  0.56 29 40.3 Day 35 B8ZX71 
Elongation factor 1-alpha 1  0.53 18 58.9 Day 7 Q90835 
Ribosomal protein L23a 0.53 3 24.5 Day 7 E1BS06 
Proteasome subunit alpha type  0.53 15 27.9 Day 21 F1NEQ6 
Collagen type V alpha 1 chain 0.49 11 57 Day 21 F1NI79 
Eukaryotic translation initiation factor 5A-1  0.47 6 63.9 Day 7 Q09121 
C-type lectin domain family 3-member B  0.45 6 40.5 Day 21 Q9DDD4 
Metalloproteinase inhibitor 2 0.42 11 67.7 Day 21 R4GIL5 













Uncharacterized protein 0.37 5 41.1 Day 21 A0A1L1S0T3 
Cathepsin D  0.37 5 87.6 Day 21 Q05744 
Sortilin 0.35 13 67.7 Day 21 A0A1D5PNT8 
Sortilin 0.28 14 25.6 Day 7 A0A1D5PNT8 
Uncharacterized protein 0.33 5 52.9 Day 7 A0A1D5PH37 
Complement C4 precursor 0.3 61 59.2 Day 35 A0A1D5P5V5 
Heparan sulfate proteoglycan 2 0.24 8 42.6 Day 21 A0A1L1RJ69 
Fibromodulin (FM)  0.14 24 62.7 Day 21 P51887 
Far upstream element-binding protein 2  0.13 13 44.1 Day 21 Q8UVD9 
1
Fold change refers to the log2 fold change in protein abundance in response to AP treatment. 
2
Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 




Table 4.3.  Proteins with significantly (p < 0.05) decreased abundance or absent in AP feed treatment samples. Proteins are listed in order of 
change of abundance. 
Protein Description Fold Change
1





Growth differentiation factor 11 Absent 2 6.4 Day 7 A0A1D5P7V6 
Uncharacterized protein Absent 5 10.3 Day 7 F1NZV7 
Uncharacterized protein Absent 3 9 Day 21 A0A1D5PF52 
Glutathione S-transferase Absent 2 9.5 Day 21 Q08392 
Catalase Absent 2 8.9 Day 21 Q5ZL24 
T-complex protein 1 subunit theta  Absent 3 6.8 Day 21 Q6EE31 
NSF attachment protein alpha Absent 2 8.2 Day 35 A0A1D5NUZ0 
Uncharacterized protein Absent 3 2.5 Day 35 A0A1D5NW21 
Fibulin-1 Absent 6 36.5 Day 35 A0A1L1RU28 
ERH, mRNA splicing and mitosis factor Absent 17 39.4 Day 35 A0A1L1RZP8 
Endoplasmic reticulum lectin 1 Absent 2 8.5 Day 35 F1NCV8 
Nuclear transport factor 2 Absent 2 63 Day 35 F1NLL4 
Nuclear transport factor 2 -0.6 4 40.7 Day 21 F1NLL4 





Protein Description Fold Change
1





Heterogeneous nuclear ribonucleoprotein A2/B1 Absent 3 20.1 Day 35 Q5ZME1 
Junction plakoglobin -1.45 33 7.1 Day 7 E1C1V3 
Uncharacterized protein -1.23 12 0.7 Day 7 A0A1L1RLW1 
Insulin like growth factor binding protein 5 -1.17 3 15.9 Day 35 F1ND88 
Fibromodulin -1.08 4 6.3 Day 35 P51887 
Fibulin 5 -1.02 7 16.7 Day 35 A0A1L1RQ98 
Serpin family D member 1 -1.00 21 37.9 Day 21 A0A1D5PLZ2 
Uncharacterized protein -0.93 2 37.5 Day 7 F1NSC7 
Uncharacterized protein -0.33 3 37.5 Day 21 F1NSC7 
Olfactomedin-like protein 3 -0.92 20 50.5 Day 35 Q25C36 
Ovoinhibitor -0.82 9 60.6 Day 7 P10184 
EGF containing fibulin like extracellular matrix 
protein 1 
-0.78 19 53.7 Day 35 A0A1D5P380 
Hemoglobin subunit alpha-D -0.77 7 90.1 Day 7 P02001 







Protein Description Fold Change
1





Carboxypeptidase -0.62 7 16 Day 21 A0A1L1RXB2 
Fibrinogen gamma chain -0.61 6 34.1 Day 7 E1BV78 
Insulin-like growth factor II -0.59 2 11 Day 35 P33717 
Uncharacterized protein -0.59 21 23.5 Day 7 A0A1D5PSJ4 
Histone H2B 8 -0.58 11 19 Day 7 Q9PSW9 
Uncharacterized protein -0.53 3 36.4 Day 21 F1NC22 
Chemerin -0.52 7 43.3 Day 35 A0A0K0PUH6 
Uncharacterized protein -0.52 2 38.5 Day 21 F1NSC8 
Matrilin-3 -0.5 53 27.9 Day 7 O42401 
Matrilin-3 -0.38 7 16.8 Day 35 O42401 
Uncharacterized protein -0.48 25 52 Day 7 R9PXM5 
Hyaluronan binding protein 2 -0.48 15 31.4 Day 21 F1NEB3 
Uncharacterized protein -0.47 8 58.7 Day 21 A0A1D5PV72 
Ig lambda chain C region -0.45 9 50.7 Day 21 P20763 
Protein-lysine 6-oxidase -0.43 7 28 Day 35 A0A1D5P1U0 






Protein Description Fold Change
1





HGF activator -0.37 11 15.6 Day 7 E1BZN8 
Collagen alpha-1(VI) chain -0.34 10 12.7 Day 35 A0A1D5PWN6 
Apolipoprotein A-I -0.25 2 90.3 Day 7 P08250 
Transforming growth factor beta induced -0.25 8 70.3 Day 7 A0A1D5NX81 
CD74 molecule -0.21 4 20.8 Day 35 F1NYL5 
ADAM metallopeptidase with thrombospondin 
type 1 motif 13 
-0.12 29 27.1 Day 35 A0A1D5PEF7 
1
Fold change refers to the log2 fold change in protein abundance in response to AP treatment. 
2 
Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 













Figure 4.5. Pathway map of 19 proteins involved in the immune system that were 
significantly increased in abundance in the serum of AP supplemented broiler chickens, 
obtained using Reactome software. Highlighted lines and dots represent proteomic 
pathways within the immune system that contain proteins which have been increased in 







4.4 Quantitative proteomic analysis of serum from broilers fed a Natustat® 
supplemented diet vs. serum from broilers fed on a control diet 
A total of 84 proteins were found to be significantly increased (p < 0.05) in abundance 
or uniquely present in the serum of NS supplemented birds across the three time points 
(Table 4.4). Proteins (n = 62) were significantly decreased in abundance (p <0.05) or 
absent from NS samples in comparison to control samples across the three time points 
(Table 4.5).  
 Principal component analysis and hierarchal clustering were conducted on 
proteomic data obtained through LC-MS/MS analysis of NS and control serum samples. 
Figure 4.6 shows PCA of NS serum samples versus control serum samples. These data 
show that NS samples and control samples cluster separately on Day 7, Day 21 and Day 
35. Hierarchal clustering was also conducted on proteomic data which matched PCA 
results on Day 7 and Day 21. However, one control sample on Day 35 clustered more 
closely with NS samples than the control group.  
 Using Reactome pathway mapping software, 21 proteins that were significantly 
increased (p <0.05) in abundance or uniquely present in NS samples were identified as 
involved in the innate immune system. These proteins are: Proteasome endopeptidase 
complex (A0A1L1RSU8), Proteasome subunit beta 1 (A0A1L1RYR5), Proteasome 26S 
subunit, ATPase 5 (F1NU79), Uncharacterized protein (F1NPN5), Alpha-1-acid 
glycoprotein (Q8JIG5), Proteasome subunit alpha type (F1NC02), Proteasome subunit 
alpha type  (A0A1L1S0K9), Proteasome subunit beta type  (A0A1L1RUE7), 
Proteasome subunit alpha type (A0A1D5PHL0), Proteasome subunit alpha type 
(F1NEQ6), Vascular cell adhesion molecule 1 (F1P201), Elongation factor 1-alpha 1 
(Q90835), Proteasome subunit alpha type  (Q5ZJX9), Peroxiredoxin-6 (F1NBV0), 
Complement Factor H (E1C7P4), Interleukin 6 signal transducer (A0A1D5PMY8), 
84 
 
Glutaminyl-peptide cyclotransferase (A0A1D5PRR0), Complement C4 precursor 
(A0A1D5P5V5), Complement C5 (E1BRS7), Complement C6  (B8ZX71) and 
Complement C7 (E1C6U2). These proteins are represented in a Reactome pathway map 
(Figure 4.7). Mannose Binding Protein (Q98TA4)  was also increased in abundance and 
approaching significance (p = 0.16) on Day 35 in NS samples (Appendix 1-Table 7.3b). 
 A number of proteins involved in ROS detoxification were significantly 
increased (p <0.05) in abundance on Day 7: specifically, Peroxiredoxin 6 (F1NBV0), 
Glutathione Peroxidase (F1NPJ8) and Glutaredoxin 3 (A0A1D5NW30). 
 A number of proteins involved in Vitamin A transport and metabolism were 
increased in abundance in NS samples. Retinol binding Protein 4 (P41263) level was 
significantly increased and Retinol binding Protein 7 (E1C0M1) was uniquely present in 
NS samples on Day 7.  
 The largest significant (p <0.05) Log2 fold-change detected across all serum 
samples was seen in the Day 35 NS vs. control comparator group. Alpha-1-acid 
glycoprotein (A1AGP) (Q8JIG5) had a Log2 fold change of 2.12 on Day 35. In order to 
see if a similar result could be obtained from another test, an A1AGP Chicken ELISA 
kit (ab157690) (abcam
®
) was used to test pooled serum samples. This assay was 
conducted on control and NS samples from Day 35, twice. Assay 1 (Appendix, Figure 
7.1) showed an increased in the mean A1AGP concentration in NS samples when 
compared to the control, increasing from 1.64 mg/ml to 2.27 mg/ml. This increase in 
abundance in NS samples was in accordance with the change observed in LC-MS/MS 
analysis, however this change was not significant (p = 0.169). The average CV% was 
17.7 in assay 1 with CV% for two replicates reaching above 30%. Assay 2 (Appendix, 
Figure 7.2) again showed an increase in the mean concentration of A1AGP in NS 
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samples, from 2.2 mg/ml to 2.3 mg/ml though this change was not significant (p = 0.6). 
The average CV% for assay 2 was 2.3%. However, the change in concentration between 
NS and control samples was smaller than the change detected in assay 1.  
 A number of proteins of note showed changes in abundance in NS samples. 
Osteocalcin (P02822) was uniquely present in NS samples on Day 21. Gastrokine-2 
(A0A1D5PFM9) was uniquely present in NS samples on Day 35. Transferrin Receptor 
protein was significantly increased (p <0.05) with a relatively large Log2 fold change 
(1.7) on Day 35. Insulin like growth factor binding protein 5 (F1ND88) was 
significantly decreased (p <0.05) on Day 35.  
 Proteins (n = 5) with involvement in carbohydrate metabolism were altered in 
abundance (p <0.05) with NS supplementation. These include N-phosphoglycerate 
kinase (F1NU17), glyceraldehyde-3-phosphate dehydrogenase (P00356) and mimecan 
(Q9W6H0) which were significantly increased (p < 0.05) in abundance in NS samples. 
N-acetyl-alpha-glucosaminidase (A0A1D5NU78) was uniquely present on Day 7. Beta-
hexosaminidase (F1NTQ2) was increased in abundance and approaching significance (p 
= 0.09) on Day 7 (Appendix 1-Table 7.2). α-Enolase (A0A1D5PSH6) was significantly 
decreased (p < 0.05) on Day 21. α-Amylase was increased in abundance and 
approaching significance (p = 0.08) on Day 7 (Appendix 1-Table 7.3b). β-Enolase 
(P07322) showed decrease in abundance and approaching significance (p = 0.09) on 
Day 21(Appendix 1 Table -7.3b) and significantly decreased (p < 0.05) in abundance on 
Day 35 (Table 4.5).  
 Proteins involved in nucleotide metabolism were significantly altered in 
abundance (p < 0.05) or unique to/absent from, NS samples. Nucleoside diphosphate 
kinase (O57535) and cytidine/uridine monophosphate kinase 2 (R4GJC4) were uniquely 
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present in NS samples on Day 21 and Day 7, respectively. Adenylate kinase isoenzyme 
(P05081) was significantly increased (p < 0.05) on Day 21 and adenosine deaminase 



















Figure 4.6. Principal Component Analysis (PCA) comparing NS (Blue) vs. control 









Table 4.4.  Proteins with significantly (p<0.05) increased abundance or unique in NS feed treatment samples. Proteins are listed in order of 
change of abundance. 







N-acetyl-alpha-glucosaminidase Unique 2 3.7 Day 7 A0A1D5NU78 
Uncharacterized protein Unique 2 1 Day 7 A0A1D5NZ61 
Dynactin subunit 2 Unique 6 22.1 Day 7 A0A1D5PGQ9 
Uncharacterized protein Unique 5 41.4 Day 7 A0A1D5PQ15 
Proteasome endopeptidase complex  Unique 3 43.7 Day 7 A0A1L1RSU8 
Proteasome subunit beta 1 Unique 3 36.4 Day 7 A0A1L1RYR5 
Retinol binding protein 7 Unique 3 32.1 Day 7 E1C0M1 
Uncharacterized protein Unique 4 30.8 Day 7 F1N8Y3 
Elongation factor 1-alpha Unique 15 49.9 Day 7 F1N9H4 
Succinyl-CoA:3-ketoacid-coenzyme A transferase  Unique 3 11 Day 7 F1N9Z7 
Endoplasmic reticulum lectin 1 Unique 3 12 Day 7 F1NCV8 
Small nuclear ribonucleoprotein 13 Unique 3 30.5 Day 7 F1NII6 
PDZ and LIM domain 5 Unique 4 8.2 Day 7 F1NTC8 











Natriuretic peptides A (Prepronatriodilatin)  Unique 3 17.9 Day 7 P18908 
Profilin Unique 2 27.9 Day 7 Q5ZL50 
Twisted gastrulation protein homolog 1 Unique 2 15.6 Day 7 Q98T89 
Cytidine/uridine monophosphate kinase 2 Unique 6 26.5 Day 7 R4GJC4 
Nucleoside diphosphate kinase  Unique 2 20.3 Day 21 O57535 
Osteocalcin  Unique 3 45.4 Day 21 P02822 
Tenascin  Unique 8 8.7 Day 21 P10039 
Gastrokine 2 Unique 2 18.6 Day 35 A0A1D5PFM9 
N-acetylglucosamine-1-phosphate transferase 
gamma subunit 
Unique 2 16 Day 35 E1BS68 
N-acetylglucosamine-1-phosphate transferase 
gamma subunit 
0.34 5 27.2 Day 7 E1BS68 
Adhesion G protein-coupled receptor G6 Unique 2 2.5 Day 35 E1C8C2 
Alpha-1-anti-ase Unique 9 27.8 Day 35 F1NPN5 
Aggrecan core protein Unique 3 2.3 Day 35 F1NZX1 
Alpha-1-acid glycoprotein 2.12 7 13.9 Day 35 Q8JIG5 












Heat shock protein beta-1 1.3 18 77.9 Day 7 F1P593 
Myosin light chain 1, skeletal muscle isoform  1.23 9 54.9 Day 7 P02604 
Myosin regulatory light chain 2, skeletal muscle 
isoform  
1.22 9 57.7 Day 7 P02609 
Adenylate kinase isoenzyme 1  1.15 11 58.1 Day 7 P05081 
Glyceraldehyde-3-phosphate dehydrogenase  1.13 20 72.1 Day 7 P00356 
Proline and arginine rich end leucine rich repeat 
protein 
1.13 10 27.9 Day 7 A0A1D5PAN0 
Glycerol-3-phosphate dehydrogenase  1.11 9 24 Day 7 A0A1D5P1Y7 
Proteasome subunit alpha type 1.08 7 36.2 Day 7 F1NC02 
Uncharacterized protein 1.08 7 21.1 Day 7 F1NIP5 
Phosphoglycerate kinase  0.94 17 51.9 Day 7 F1NU17 
Complement C5 0.93 82 54.8 Day 35 E1BRS7 
Dynactin subunit 3 0.89 6 32.9 Day 7 A0A1D6UPU1 













Uncharacterized protein 0.86 7 15.2 Day 7 A0A1L1RQM3 
Low molecular weight phosphotyrosine protein 
phosphatase 
0.84 10 58.5 Day 7 A0A1D5P9Z1 
Proteasome subunit alpha type  0.84 9 46.3 Day 7 A0A1L1S0K9 
Protein/nucleic acid deglycase DJ-1 0.84 5 51.4 Day 7 A0A1D5PN39 
Complement C6  0.83 29 33.4 Day 35 B8ZX71 
Proteasome subunit beta type 0.79 13 56.6 Day 7 A0A1L1RUE7 
Proteasome subunit alpha type  0.79 5 36.1 Day 7 A0A1D5PHL0 
Periostin 0.77 16 24.5 Day 21 F1P4N9 
Receptor of-activated protein C kinase 1 0.76 9 40.9 Day 7 A0A1I7Q3Y2 
Proteasome subunit alpha type  0.76 6 23.9 Day 7 F1NEQ6 
Serpin H1  0.76 12 34.9 Day 7 P13731 














Ribosomal protein S14 0.69 4 34.9 Day 7 Q5ZHW8 
T-complex 1 0.68 9 17.6 Day 7 Q5ZMG9 
Uncharacterized protein 0.67 8 38.3 Day 7 A0A1D5PAH2 
Complement C7 0.66 28 52.3 Day 35 E1C6U2 
T-complex protein 1 subunit zeta  0.64 20 51.8 Day 7 Q5ZJ54 
Elongation factor 1-alpha 1  0.63 18 54 Day 7 Q90835 
Retinol-binding protein 4  0.61 11 68.9 Day 7 P41263 
Proteasome subunit alpha type  0.6 6 41.5 Day 7 Q5ZJX9 
Nuclear transport factor 2 0.55 3 33.9 Day 7 F1NLL4 
Chaperonin containing TCP1 subunit 5 0.55 17 34.4 Day 7 Q5F411 
40S ribosomal protein S12 0.54 7 61.4 Day 7 P84175 
Uncharacterized protein 0.54 6 39.8 Day 35 A0A1D5PK48 
Peroxiredoxin-6 0.53 12 66.4 Day 7 F1NBV0 
Uncharacterized protein 0.51 6 40.2 Day 35 A0A1D5PZU8 













Glia maturation factor beta 0.5 5 31.6 Day 7 A0A1D6UPR3 
Complement C4 precursor 0.48 61 45.6 Day 35 A0A1D5P5V5 
Collagen type V alpha 1 chain 0.46 6 4.8 Day 21 F1NI79 
Insulin like growth factor binding protein acid 
labile subunit 
0.44 8 15.4 Day 21 F1NI07 
TRK-fused gene 0.41 4 12.9 Day 7 A0A1L1RK44 
Complement factor B-like protease  0.39 6 36.8 Day 7 P81475 
Nidogen 2 0.36 20 16.3 Day 35 F1NDL4 
Uncharacterized protein 0.35 5 17.6 Day 7 Q5ZMC1 
Complement factor H 0.32 93 71.5 Day 7 E1C7P4 
Glutathione peroxidase 0.3 11 45.9 Day 7 F1NPJ8 
Interleukin 6 signal transducer 0.29 3 5 Day 7 A0A1D5PMY8 













Glutaminyl-peptide cyclotransferase 0.26 13 58.5 Day 7 A0A1D5PRR0 
Fibromodulin  0.23 2 3.7 Day 21 P51887 
Mimecan  0.15 9 32.7 Day 35 Q9W6H0 
1
Fold change refers to the log2 fold change in protein abundance in response to NS treatment. 
2
Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 







Table 4.5.  Proteins with significantly (p<0.05) decreased abundance or absent in NS feed treatment samples. Proteins are listed in order of 
change of abundance. 







Malate dehydrogenase  Absent 3 23.3 Day 7 A0A1D5PZS3 
Junction plakoglobin  Absent 6 10.4 Day 7 E1C1V3 
Uncharacterized protein Absent 2 19.1 Day 7 R4GIC2 
DEAD-box helicase 17 Absent 3 6.1 Day 21 A0A1D5PD32 
Uncharacterized protein Absent 3 9 Day 21 A0A1D5PF52 
V-type proton ATPase subunit B, brain isoform Absent 3 11.3 Day 21 A0A1D5PP57 
Splicing factor proline and glutamine rich Absent 3 18.4 Day 21 A0A1D5PPW4 
Glutathione S-transferase  Absent 2 9.5 Day 21 Q08392 
T-complex protein 1 subunit theta  Absent 3 6.8 Day 21 Q6EE31 
NSF attachment protein alpha Absent 2 8.2 Day 35 A0A1D5NUZ0 
Uncharacterized protein Absent 3 2.5 Day 35 A0A1D5NW21 
Glia maturation factor beta Absent 2 28 Day 35 A0A1D6UPR3 
Uncharacterized protein Absent 5 11.7 Day 35 E1BSP1 












Serpin family F member 2 -2.17 13 24.2 Day 7 F1NAR5 
Beta-enolase -1.65 12 40.9 Day 35 P07322 
Receptor of-activated protein C kinase 1 -1.33 6 21.9 Day 21 A0A1I7Q3Y2 
Serpin family G member 1 -1.24 12 15.8 Day 7 F1NA58 
Uncharacterized protein -1.18 2 0.7 Day 7 A0A1L1RLW1 
Tubulin beta-7 chain  -1.18 12 40.1 Day 21 P09244 
Uncharacterized protein -1.11 11 8.6 Day 21 A0A1L1RJ91 
Phosphoglycerate kinase  -1.03 11 27.8 Day 21 A0A1D5NZW9 
Fibulin 5 -0.85 7 17.2 Day 35 A0A1L1RQ98 
Elongation factor 1-alpha 1 -0.84 16 49.7 Day 21 Q90835 
Pyruvate kinase PKM  -0.83 26 45.6 Day 35 P00548 
Adenosine deaminase  -0.8 17 60.4 Day 35 Q5ZKP6 
DAZ associated protein 1 -0.79 4 15.4 Day 21 Q5ZM92 
Alpha-enolase -0.74 14 34.3 Day 21 A0A1D5PSH6 













Macrophage receptor with collagenous structure -0.71 10 21.4 Day 21 A0A1D5PJZ3 
Adenosine deaminase -0.7 20 69.8 Day 21 A0A1D5PDK4 
Tubulin alpha chain -0.68 11 30.3 Day 21 A0A1D5PC38 
Uncharacterized protein -0.68 10 30.3 Day 21 E1C477 
Heterogeneous nuclear ribonucleoprotein K -0.68 3 8.4 Day 21 A0A1L1S010 
T-complex protein 1 subunit zeta -0.67 14 31.2 Day 21 Q5ZJ54 
Phosphoglycerate mutase 1  -0.62 9 25.4 Day 35 Q5ZLN1 
Tubulin beta-6 chain  -0.62 14 38.2 Day 21 P09207 
LSM8 homolog, U6 small nuclear RNA 
associated 
-0.6 4 55.9 Day 21 E1BZ75 
Chaperonin containing TCP1 subunit 2 -0.57 11 26.5 Day 21 Q5F424 
Alpha-actinin-1 -0.56 4 4.8 Day 21 A0A1D5P9P3 
Uncharacterized protein -0.54 7 18.5 Day 21 F1NIP5 
Complement C1q C chain -0.52 5 24 Day 21 A0A1D5PGB2 
Kininogen 1 -0.52 15 28.1 Day 7 A0A1L1RNR4 
Complement C1q B chain -0.51 6 33.6 Day 21 F1NH19 












Vitronectin -0.48 15 39.5 Day 7 E1C7A7 
Fibulin-1  -0.46 23 39.3 Day 35 O73775 
Ubiquilin 4 -0.46 5 12.4 Day 21 A0A1D5P624 
Methylthioribose-1-phosphate isomerase 1 -0.46 9 46.6 Day 21 A0A1D5PN97 
EGF containing fibulin like extracellular matrix 
protein 1 
-0.45 19 52.7 Day 35 A0A1D5P380 
Far upstream element binding protein 1 -0.45 12 21.5 Day 21 A0A1D5P2H3 
Apolipoprotein H -0.44 14 42.7 Day 35 A0A1L1RTQ4 
Epiphycan  -0.43 5 13.7 Day 7 Q90944 
Ig lambda chain C region -0.42 9 53.3 Day 35 P20763 
Aggrecan core protein -0.38 16 7.7 Day 7 F1NZX1 
Fibulin-1 -0.38 18 31.8 Day 21 A0A1L1RU28 
Uncharacterized protein -0.34 43 25.4 Day 35 F1NEQ4 
Far upstream element-binding protein 2  -0.3 13 18.7 Day 21 Q8UVD9 
F-actin-capping protein subunit beta isoforms 1 
and 2 












Uncharacterized protein -0.28 2 38.5 Day 21 F1NSC8 
Vimentin -0.27 30 64.6 Day 21 A0A1L1RXL9 
Fibrinogen gamma chain -0.18 9 33.7 Day 7 E1BV78 
1
Fold change refers to the log2 fold change in protein abundance in response to NS treatment. 
2
Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 













Figure 4.7. Pathway map of 19 proteins involved in the immune system that were 
significantly increased in abundance or uniquely present in the serum of NS 











4.5 Quantitative proteomic analysis of serum from broilers fed a PowerTract® 
supplemented diet vs. serum from broilers fed on a control diet. 
Proteins (n = 64) were found to be significantly increased (p < 0.05) in abundance or 
uniquely present in PT samples when compared to control, across all time points (Table 
4.6). Proteins (n = 54) were significantly decreased (p < 0.05) or absent from PT 
samples across all time points (Table 4.7). 
 Principal component analysis and hierarchal clustering were conducted on 
proteomic data obtained through LC-MS/MS analysis of PT and control serum samples. 
Figure 4.8 shows PCA of PT serum samples versus control serum samples. These data 
reveal that PT samples and control samples cluster separately on Day 7, Day 21 and 
Day 35. Hierarchal clustering was also conducted on proteomic data which did not 
match PCA grouping on Day 35, although samples largely grouped together on Day 7 
and Day 21 (data not shown). 
 Using the Reactome pathway mapping software, 17 proteins that were found to 
be significantly increased (p < 0.05) in abundance or uniquely present in PT samples, 
were identified as involved in the innate immune response. These proteins are: 
Uncharacterised protein (F1NPN5), Proteasome subunit beta 1 (A0A1L1RYR5), 
Complement factor H (E1C7P4), Proteasome 26S subunit, ATPase 5 (F1NU79), Dual 
specificity phosphatase 3 (A0A1L1S0I4), Chromogranin A (F1NLZ2), Transthyretin  
(P27731), Alpha-1,4 glucan phosphorylase (E1BSN7), Proteasome subunit alpha type 
(F1NEQ6), Beta-2-microglobulin (P21611), Beta-hexosaminidase (F1NTQ2), 
Complement C2 (A0A1D5P4P1), Complement C4 precursor (A0A1D5P5V5), 
Complement C5 (E1BRS7), Complement C6 (B8ZX71), Complement C7 (E1C6U2) 
and Mannose-binding protein (Q98TA4). These proteins are represented in a Reactome 
pathway map in Figure 4.9. 
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 Proteins (n = 4) involved in carbohydrate metabolism showed changes in 
abundance in PT samples. Glyceraldehyde-3-phosphate dehydrogenase (P00356) was 
significantly increased (p < 0.05) on Day 7. Glutamate dehydrogenase 1 and Beta-1,4-
galactosyltransferase 4 (E1C9B0) were absent from PT samples on Day 7.  
 Proteins (n = 4) involved in nucleotide metabolism showed significant (p < 0.05) 
alterations in abundance in PT samples. Adenylate kinase isoenzyme significantly 
increased (p < 0.05) on Day 7. Guanine Deaminase (F1NJD6) significantly decreased (p 
<0.05) on Day 21. Adenosine deaminase (A0A1D5PDK4) significantly decreased (p < 
0.05) on Day 35. Deoxythymidylate kinase (A0A1D5PKC2) was absent from PT 
samples on Day 7. 
 Proteins (n = 2) involved in Vitamin A transport increased in abundance in PT 
samples. Retinol binding protein 4 (P41263) was increased in abundance and 
approaching significance (p = 0.06) on Day 21. Transthyretin (P27731) was 
significantly increased (p < 0.05) in abundance on Day 35. 
 Many key proteins involved in the detoxification of ROS were significantly 
decreased (p < 0.05) in abundance or absent from PT samples. Two Catalase proteins 
were absent from PT samples on Day 7 and Day 21, respectively, Catalase 
(A0A1D5PPU9) and Catalase (Q5ZL24). Peroxiredoxin-1 (P0CB50) was significantly 
decreased in abundance on Day 35. Glutathione Peroxidase (F1NPJ8) was increased in 
abundance and approaching significance (p = 0.08 and 0.09 respectively) in PT samples 
on Day 21 (Appendix 1- Table 7.5) and Day 35 (Appendix 1- Table 7.5b). Glutathione-
S-Transferase (GST) (Q08392) was absent from PT samples in all time points, this 
protein was identified as GST alpha-class.  
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 A number of proteins showed changes in abundance in PT samples. Transferrin 
Receptor Protein was significantly increased (p < 0.05) on Day 35. Gastrin releasing 
peptide (A0A1D5PXC4) was significantly decreased (p < 0.05) in abundance on Day 
35.  
 PT-supplemented birds were the only group fed an organic source of selenium in 
their diet instead of the inorganic source selenium selenite. In order to examine any 
potential effects of this change in selenium source, control and PT samples were 
examined for a SeMet/SeCys substitution for methionine/cysteine using MQ. Control 
and PT samples were also searched for known selenoproteins. There was one protein 
identified as having SeMet/SeCys substitution in control samples (Table 4.8) this 
protein was SEC31 homolog B, COPII coat complex component (E1BXC8). The 
protein was detected in only one control sample with a sequence coverage of 3.6% and 
1 peptide detected. Proteins (n = 4) were identified as having a SeMet/SeCys 
substitution in PT samples (Table 4.9), Coatomer subunit alpha (A0A1D5P185), Golgin 
A4 (A0A1D5PNT3), Nuclear factor related to kappaB binding protein (E1BZI6) and 
Translocase of outer mitochondrial membrane 34 (F1P4X4). The sequence coverage of 
proteins identified was low, namely 0.8-5.4%. Of the four proteins identified with a 
SeMet/SeCys substitution, three were identified in one PT pooled serum sample 
obtained on Day 7.  
 Using a list of previously identified selenoproteins obtained from Liu et al. 
(2017) (Appendix 1-Table 7.7), one selenoprotein was identified in PT and control 
samples, Glutathione Peroxidase (F1NPJ8). This protein was increased in abundance 
with p-value approaching significance on Day 21 (p = 0.08) and Day 35 (p = 0.09) 
(Table 4.10). Selenoprotein F precursor (A0A1D5PFR6) was uniquely detected in PT 
samples, but was not detected in AP, NS and control samples. 
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Alpha-1-Acid Glycoprotein was increased in abundance on Day 35 in samples from PT 
supplemented birds with a large fold change (Appendix 1-Table 7.6). However, this 



































Figure 4.8. Principal Component Analysis (PCA) graphs comparing PT (Green) vs. 








Table 4.6.  Proteins with significantly (p<0.05) increased abundance or unique in PT feed treatment samples. Proteins are listed in order of 
change of abundance. 







Barrier to autointegration factor 1 Unique 2 42.2 Day 7 A0A1D5NXY4 
HSPA (Hsp70) binding protein 1 Unique 5 12.1 Day 7 A0A1D5P628 
Uncharacterized protein Unique 9 41.4 Day 7 A0A1D5PQ15 
Proteasome subunit beta 1 Unique 4 36.4 Day 7 A0A1L1RYR5 
Ankyrin repeat domain 2 Unique 5 8.9 Day 7 E1C1Q6 
Plexin domain containing 2 Unique 3 5.9 Day 7 E1C486 
Mediator of cell motility 1 Unique 2 21.9 Day 7 E1C6C0 
3'-phosphoadenosine 5'-phosphosulfate synthase 1 Unique 3 12.3 Day 7 E1C8P2 
Elongation factor 1-alpha Unique 3 49.9 Day 7 F1N9H4 
Four and a half LIM domains 1 Unique 3 18.5 Day 7 F1NED9 
Small nuclear ribonucleoprotein 13 Unique 4 30.5 Day 7 F1NII6 
Chromogranin A Unique 3 10.7 Day 7 F1NLZ2 












Proteasome 26S subunit, ATPase 5 Unique 2 12.7 Day 7 F1NU79 
Uncharacterized protein Unique 2 14.1 Day 7 F1NWB2 
Natriuretic peptides A  Unique 2 17.9 Day 7 P18908 
Cofilin-2  Unique 4 25.9 Day 7 P21566 
Stratifin Unique 15 28.5 Day 7 R4GF89 
Seryl-tRNA synthetase Unique 3 4.3 Day 7 R4GJ59 
Disintegrin and metalloproteinase domain-
containing protein 33 precursor 
Unique 2 3.6 Day 21 A0A1D5NV10 
Gastrokine 2 Unique 3 18.6 Day 35 A0A1D5PFM9 
Dual specificity phosphatase 3 Unique 2 26.3 Day 35 A0A1L1S0I4 
Alpha-1-anti-ase Unique 2 27.8 Day 35 F1NPN5 
Aggrecan core protein Unique 2 2.3 Day 35 F1NZX1 
Insulin-like growth factor I  Unique 3 19.0 Day 35 P18254 
Zyxin Unique 5 4.8 Day 35 Q04584 
Adenylate kinase isoenzyme 1  1.12 11 60.3 Day 7 P05081 












Myosin regulatory light chain 2, skeletal muscle 
isoform  
1.07 9 57.8 Day 7 P02609 
Uncharacterized protein 1.04 2 19.2 Day 35 A0A1D5P1L5 
Complement C5 1.04 82 55.5 Day 35 E1BRS7 
Heat shock protein beta-1 1.03 18 77.9 Day 7 F1P593 
Transthyretin  1.00 9 71.4 Day 35 P27731 
Glyceraldehyde-3-phosphate dehydrogenase  0.95 20 72.0 Day 7 P00356 
Uncharacterized protein 0.94 4 37.9 Day 21 A0A1L1RQF3 
Myosin light chain 1, skeletal muscle isoform  0.90 9 53.9 Day 7 P02604 
Alpha-1,4 glucan phosphorylase  0.89 5 6.5 Day 35 E1BSN7 
Uncharacterized protein 0.79 6 39.8 Day 35 A0A1D5PK48 
Actin, alpha skeletal muscle 0.78 13 34.8 Day 21 A0A1I7Q414 
Low molecular weight phosphotyrosine protein 
phosphatase 
0.75 10 58.5 Day 7 A0A1D5P9Z1 
Uncharacterized protein 0.70 7 21.5 Day 7 F1NIP5 













Complement C7 0.68 28 52.0 Day 35 E1C6U2 
Uncharacterized protein 0.67 4 37.1 Day 35 A0A1L1RQF3 
Uncharacterized protein 0.63 18 22.3 Day 35 A0A1L1S0T3 
Uncharacterized protein 0.60 2 23.0 Day 21 A0A1D5P058 
Uncharacterized protein 0.56 5 42.3 Day 35 F1NSC7 
Complement C4 precursor 0.55 61 48.1 Day 35 A0A1D5P5V5 
Mannose-binding protein  0.50 8 27.5 Day 35 Q98TA4 
Proteasome subunit alpha type  0.45 6 23.5 Day 7 F1NEQ6 
Beta-2-microglobulin 0.45 5 60.5 Day 21 P21611 
Uncharacterized protein 0.44 4 38.5 Day 35 F1NSC8 
Beta-hexosaminidase  0.42 20 49.2 Day 7 F1NTQ2 
Sortilin 0.41 14 20.9 Day 7 A0A1D5PNT8 
RAD23 homolog B, nucleotide excision repair 
protein 














Complement C2 0.41 2 15.7 Day 35 A0A1D5P4P1 
Vascular cell adhesion molecule 1 0.39 9 12.3 Day 21 F1P201 
Uncharacterized protein 0.38 6 21.3 Day 21 A0A1L1S0T3 
Complement factor H 0.28 15 71.9 Day 21 E1C7P4 
Plasminogen  0.23 94 69.7 Day 21 R4GMH5 
Apolipoprotein A-I  0.20 57 92.8 Day 21 P08250 
Uncharacterized protein 0.19 55 17.3 Day 7 Q5ZMC1 
Lumican  0.17 5 39.2 Day 35 P51890 
Prolyl 4-hydroxylase subunit alpha-1 0.13 11 21.5 Day 7 P16924 
1
Fold change refers to the log2 fold change in protein abundance in response to PT treatment. 
2
Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 




Table 4.7.  Proteins with significant (p <0.05) decreased abundance or absent in PT feed treatment samples. Proteins are listed in order of 
change of abundance. 







Glutamate dehydrogenase 1, mitochondrial Absent 4 9.9 Day 7 A0A1D5NT61 
Growth differentiation factor 11 Absent 2 6.4 Day 7 A0A1D5P7V6 
Catalase  Absent 3 5.3 Day 7 A0A1D5PPU9 
Malate dehydrogenase  Absent 3 23.3 Day 7 A0A1D5PZS3 
Integral membrane protein 2B Absent 2 46.2 Day 7 A0A1L1RIU5 
Uncharacterized protein Absent 2 0.9 Day 7 A0A1L1RLW1 
Beta-1,4-galactosyltransferase 4 Absent 2 8.5 Day 7 E1C9B0 
Carbamoyl-phosphate synthase 1 Absent 4 3.3 Day 7 F1N9N8 
Glutathione S-transferase  Absent 2 9.5 Day 7 Q08392 
NSF attachment protein alpha Absent 2 8.2 Day 21 A0A1D5NUZ0 
Uncharacterized protein Absent 3 9 Day 21 A0A1D5PF52 
Deoxythymidylate kinase Absent 3 22.6 Day 21 A0A1D5PKC2 
Lysophospholipase II Absent 2 19 Day 21 E1BRI5 











Proteasome 26S subunit, ATPase 5 Absent 3 12.7 Day 21 F1NU79 
Glutathione S-transferase  Absent 2 9.5 Day 21 Q08392 
Catalase Absent 2 8.9 Day 21 Q5ZL24 
Carbohydrate sulfotransferase 3  Absent 4 13.3 Day 21 Q92179 
NSF attachment protein alpha Absent 2 8.2 Day 35 A0A1D5NUZ0 
Uncharacterized protein Absent 3 2.5 Day 35 A0A1D5NW21 
Reversion inducing cysteine rich protein with 
kazal motifs 
Absent 6 8.9 Day 35 A0A1D5PTW4 
Uncharacterized protein Absent 3 29.6 Day 35 A0A1D5PZ95 
Glutathione S-transferase  Absent 2 9.5 Day 35 Q08392 
TAR DNA-binding protein 43  Absent 3 14.5 Day 35 Q5ZLN5 
Heterogeneous nuclear ribonucleoprotein A2/B1 Absent 5 20.1 Day 35 Q5ZME1 
Cytidine/uridine monophosphate kinase 2 Absent 5 25.7 Day 35 R4GJC4 














Fibromodulin  -1.20 4 7.7 Day 35 P51887 
Tubulin beta-7 chain  -1.20 12 39.7 Day 21 P09244 
Beta-tropomyosin  -1.18 27 62.2 Day 35 Q05705 
Integrin-linked kinase -1.11 4 10.3 Day 35 Q9DF58 
cAMP-dependent protein kinase type I-alpha 
regulatory subunit 
-1.02 11 27.4 Day 35 Q5ZM91 
Fibulin 5 -0.90 7 16.8 Day 35 A0A1L1RQ98 
cAMP-dependent protein kinase type I-alpha 
regulatory subunit 
-0.89 6 20.3 Day 21 Q5ZM91 
Tropomyosin alpha-1 chain -0.84 12 47.6 Day 21 A0A1D5P342 
MHC class II beta chain 2 -0.82 3 14.8 Day 21 A5HUL4 















Beta-tropomyosin  -0.71 22 61.3 Day 21 Q05705 
Hyaluronan binding protein 2 -0.70 15 32.5 Day 21 F1NEB3 
Phosphatidylcholine-sterol acyltransferase  -0.68 13 37.4 Day 21 P53760 
Heat shock protein beta-1 -0.67 17 79.4 Day 35 F1P593 
Collagen alpha-2(I) chain  -0.65 11 10.1 Day 35 P02467 
Complement C7 -0.61 21 43.8 Day 7 E1C6U2 
Alpha-actinin-1 -0.48 4 4.37 Day 21 A0A1D5P9P3 
DAZ associated protein 1 -0.47 4 14.0 Day 21 Q5ZM92 
Adenosine deaminase -0.41 17 65.6 Day 35 A0A1D5PDK4 
Alpha-actinin-1 -0.41 15 12.7 Day 35 A0A1D5P9P3 
Chemerin -0.41 7 46.2 Day 35 A0A0K0PUH6 
Collagen type XVIII alpha 1 chain -0.40 5 4.7 Day 35 A0A1D5P5M7 
Guanine deaminase -0.38 8 23.5 Day 21 F1NJD6 
Macrophage receptor with collagenous structure -0.33 10 21.4 Day 21 A0A1D5PJZ3 













Fibulin-1 -0.16 18 31.1 Day 21 A0A1L1RU28 
Heterogeneous nuclear ribonucleoprotein M -0.15 6 7.7 Day 21 F7B5K7 
1
Fold change refers to the log2 fold change in protein abundance in response to PT treatment. 
2
 Coverage (%) refers to the % of protein sequence 
represented by identified peptides. 
3
Day refers to the time point at which the differently abundant protein was detected: Day 7, Day 21 or Day 35 














Figure 4.9. Pathway map of 19 proteins involved in the immune system that were 
significantly increased in abundance or uniquely present in the serum of PT 











Table 4.8. Proteins in control samples which were detected to have a SeMet/SeCys substitution. 
Protein Description Sample Pool Coverage (%)
1 
Peptides Substitution Site Position Accession 
SEC31 homolog B, COPII coat complex 
component 
Day 7 Pen 7 Pool 3.6 1 4;5 E1BXC8 
1
 Coverage (%) refers to the % of protein sequence represented in identified peptides. 
Table 4.9. Proteins in PT samples which were detected to have a SeMet/SeCys substitution 
Protein Description Sample Pool Coverage (%)
1 
Peptides Substitution Site Position Accession 
Coatomer subunit alpha Day 7 Pen 9 Pool 0.8 1 719;720 A0A1D5P185 
Golgin A4 Day 7 Pen 9 Pool 1.2 2 1320 A0A1D5PNT3 
Nuclear factor related to kappaB binding 
protein 
Day 7 Pen 9 Pool 0.8 1 934 E1BZI6 
Translocase of outer mitochondrial membrane 
34 
Day 35 Pen 2 Pool 5.4 2 307 F1P4X4 
1
 Coverage (%) refers to the % of protein sequence represented by identified peptides. 
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Day 7 0.099 0.44 45.4 11 
Day 21 0.36 0.08 56.0 14 
Day 35 0.78 0.09 58.3 15 
1
Day refers to the time point at which Glutathione Peroxidase was detected: Day 7, Day 21 or Day 35 of feed trial.
2
Fold change refers to the log2 
fold change in protein abundance in response to PT treatment. 
3






4.6 Discussion  
The supplementation of broiler diets with AP, NS and PT was seen to significantly alter 
the abundance of many proteins with various functions in the health and immune status 
of the broiler chicken. Changes in abundance were seen in proteins involved in the 
innate immune system, nutrient transport, oxidative stress and selenium status - all of 
which contribute to the overall health of the animal. 
4.6.1 Proteomic Results Overview 
Supplementation of broiler diet with YCW products had a relatively small but notable 
effect on the serum proteome with averages of 6.31% - 7.78% of proteins significantly 
changed in abundance (p < 0.05) or unique/absent in the serum of AP-, NS- and PT-
treated birds. NS samples showed the largest number of protein changes with 85 
proteins significantly increased in abundance (p < 0.05) or uniquely present in 
comparison to control, and 63 proteins significantly decreased in abundance (p < 0.05) 
or absent in comparison to control. PT samples showed the lowest total number of 
proteins changed with 65 proteins significantly increased in abundance (p < 0.05) or 
uniquely present in comparison to control, and 55 proteins significantly decreased in 
abundance (p < 0.05) or absent in comparison to control. This could suggest that of the 
three feed diets, NS supplementation has the greatest effect on broilers. However 
samples from PT supplemented birds showed the greatest number of proteins that were 
unique to a treatment in inter-treatment analysis and, as will be discussed later in this 
section, PT showed greater complement activation as well as alterations to the selenium 
status of the animal which may indicate a larger effect.  
 There is a small disparity in the protein number between the inter-day and inter-
treatment comparators. The total number of proteins identified in inter-treatment 
analysis is slightly lower (n = 986) than the total identified in inter-day analysis (n = 
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1007). This is due to the action of MQ data analysis software, such that there were 
slight differences in protein annotation when samples were grouped by day and grouped 
by treatment. This disparity, however, would not affect quantitative results as all 
samples from the same time point were grouped together in one analytical run in MQ, 
thereby keeping annotations constant between all feed groups. 
 PCA was conducted on each comparator group within each treatment group to 
ensure samples were grouped together and so could be comparable through the LC-
MS/MS data obtained. In all PCA plots, treatment and control samples grouped 
separately. This result was not matched exactly in every comparator group during 
hierarchical clustering. The cross-over seen in hierarchical clustering is likely a function 
of the variability of biological replicates combined with the relatively small effects of 
these feed supplements on the serum proteome.  
4.6.2 Immunological Effects 
As previously stated, YCW products can have numerous immunological effects on 
animals (Gao et al., 2003; Chae et al., 2006; Goodridge et al., 2009; Dalonso et al., 
2015; Song et al., 2014; Hoving et al., 2018). The increase in abundance of a number of 
immunological proteins suggests immunostimulatory/immunomodulatory effects by 
these YCW products.  
 One likely mediator of this immunostimulation is Surfactant Protein A 
(Q90XB2). This protein is uniquely present in AP samples on Day 7. This protein is a 
C-type lectin receptor which is present in mucosal tissues and binds glycan ligands 
which can result in downstream immunological effects (Haagsman et al., 2008). 
Carbohydrate recognition domains on this protein bind glycan residues resulting in 
innate immune stimulation (Turner, 2003) which could explain the increase in 
abundance of immune-related proteins observed. 
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 Across all treatment groups, there were significant (p < 0.05) increases in the 
level of a number of complement components in the serum of YCW-supplemented 
broilers harvested on Day 35, which would indicate stimulation of the complement 
cascade by the YCW feed products. Complement C4 precursor (A0A1D5P4P1), 
Complement C6 (B8ZX71) and Complement C7 (E1C6U2) were significantly increased 
(p < 0.05) in all treatments samples on Day 35. Complement C5 (E1BRS7) was 
increased in abundance and approaching significance in AP samples (Table 7.1) and 
was significantly increased (p < 0.05) in abundance in NS and PT samples. Complement 
C2 was significantly increased (p < 0.05) in abundance in PT samples only. PT samples 
showed the greatest level of complement stimulation. Increases in serum levels of 
complement components indicate a stimulation of the complement cascade by these 
YCW feed supplements.  
 A possible source of this complement stimulation by YCW products is through 
activation of the complement cascade by mannose binding protein (Q98TA4). This 
protein was significantly increased (p < 0.05) in abundance in PT samples and increased 
and approaching significance in AP (p = 0.2) and NS (p = 0.162) samples on Day 35. 
Mannose Binding protein, also called Mannose Binding Lectin (MBL) (Fraser et al., 
1998; Worthley et al., 2005), is a C-type serum lectin (Ulrich-Lynge et al., 2015) that 
binds mannose residues which results in C1-independent complement activation and 
binding leads to cleavage of C2 and C4 from their precursors by associated serine 
proteases (Davis et al., 2004). Both C2 and C4 precursor were significantly increased in 
abundance (p < 0.05) in PT samples. MBL may also interact directly with cell surface 
receptors which can initiate opsonophagocytosis (Turner, 2003) causing 
immunostimulation which could also explain the abundance rise in proteins which have 
been linked with the innate immune system. Interestingly, low serum concentrations of 
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MBL has been linked to a greater susceptibility to infection (Ulrich-Lynge et al., 2015). 
There was little data available in the literature regarding stimulation of the chicken 
complement cascade by YCW feed supplementation. One study by Slawinska et al. 
(2016) reported a downregulation of two genes influencing the complement system after 
in ovo administration of yeast-based prebiotics to broiler chickens followed by 
transcriptomic analysis. Activation of the complement system by carbohydrate-based 
feed has been previously seen in aquaculture. Gilthead seabream were fed a diet 
supplemented with inulin, a branched carbohydrate comparable to β-glucan or MOS 
(Mensink et al., 2015). Supplementation resulted in significant increases (p < 0.05) in 
serum complement activity (Cerezuela et al., 2012) which is in accordance with results 
found in the present study. 
 MOS-based products have been shown to elicit immunological responses 
without causing acute phase (fever) response (Yang et al., 2009). Yet, the largest fold 
change was seen (Log2 Fold change = 2.12) for alpha-1-acid glycoprotein (A1AGP) in 
LC-MS/MS analyses. This protein is in high abundance in serum and has been 
previously characterised as an acute phase protein (Horvatić et al., 2018). Large fold 
changes in A1AGP were also seen between samples from AP and PT supplemented 
birds and control samples (Log2 fold change = 3.69 and 1.86, respectively) although the 
p-value for these changes was not significant (p = 0.37 and 0.36, respectively).  
 The high fold changes noted with this protein could suggest the stimulation of 
the acute phase response. However, non-significant p-values (p <0.05) seen in AP and 
PT as well as the lack of significant change (p <0.05) in any other acute phase proteins 
would suggest that increases in the abundance of this protein may not represent an acute 
phase response but rather the natural variability of the serum level of this protein.  
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 In order to ascertain whether this result could be replicated using another form 
of analysis, an A1AGP assay was carried out using NS and control samples. Upon first 
analysis, a high CV% was seen, particularly in two samples (CV% > 30%). This was 
likely due to familiarisation with the assay. The second assay showed a low CV%, with 
NS showing slightly higher concentration of A1AGP than control. Though no 
significant change (p < 0.05) was detected using this alternative method for A1AGP 
quantification, the results did show an increase in mean A1AGP concentration which 
was in accordance with the results obtained from LC-MS/MS analysis.  
4.6.3 Effects on Metabolism 
With YCW supplementation, a number of proteins involved in carbohydrate and 
nucleotide metabolism were significantly altered (p <0.05) in abundance across all 
treatment groups. Glyceraldehyde-3-phosphate dehydrogenase (P00356) was 
significantly increased (p < 0.05) in all treatment groups on Day 7. This protein is 
involved in glycolysis (Rodacka, 2013) and its increase could indicate a greater level of 
glycolysis in birds supplemented with these YCW products. Beta-hexosaminidase 
(F1NTQ2) was significantly increased (p < 0.05) in abundance in PT samples and 
increased and approached significance (p = 0.08) (Table 7.5) in NS samples on Day 7. 
This protein is involved in the release of N-acetylglucosamine and N-
acetylgalactosamine from glycoproteins, which are in high concentration in the YCW 
(Dasgupta, 2015) and its increase in abundance is likely a result of the increased 
glycoprotein substrate in the diet. Increase in the abundance of these proteins could 
indicate that the introduction of these feed supplements is stimulating carbohydrate 
metabolism in broiler chickens. However, individual products had varying effects on the 
levels of carbohydrate metabolism proteins. NS had a variable effect on carbohydrate 
metabolism. Proteins (n = 4), involved in carbohydrate metabolism were significantly 
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increased in abundance (p < 0.05) or uniquely present in NS samples. However, other 
proteins involved in carbohydrate metabolism showed a decrease in abundance such as 
α-Enolase (A0A1D5PSH6) and β-Enolase (P07322). PT also had an inconsistent effect 
on the abundance of proteins involved in carbohydrate metabolism, with proteins both 
significantly increased (p <0.05) and significantly decreased (p<0.05) in abundance. 
Overall the levels of proteins involved in carbohydrate metabolism were variable and, 
though significant changes (p < 0.05) were seen, no definitive effect on carbohydrate 
metabolism could be deduced.  
 Differential effects were also seen on proteins involved in nucleotide 
metabolism throughout all three products. Significant changes (p < 0.05) in the 
abundance of multiple proteins involved in this process would suggest an effect of 
YCW supplementation, but with proteins both increased and decreased in abundance, 
no common trend could be elucidated. 
4.6.4 Individual Proteins of Note 
A number of individual proteins of note were seen to be significantly altered in 
abundance (p < 0.05) or present/absent in treatment groups with interesting links to a 
number of aspects in animal health. Gastrokine-2 is secreted by gastric mucosal cells. 
This protein binds Gastrokine-1 and is involved in regulating homeostasis of gastric 
mucosa (Menheniott et al., 2016). It has been documented that YCW feed 
supplementation can have effects on gastric mucosa (Brümmer et al., 2010). Gastokine-
2 was seen to be uniquely present in the serum of AP and NS samples on Day 35. One 
other protein involved in the regulation of gastric mucosa is Gastrin releasing peptide 
(A0A1D5PXC4). This protein was significantly reduced (p <0.05) in PT samples on 
Day 35. Changes in the abundance of these proteins would indicate that these YCW 
products have an effect on the regulation of the gut mucosa. 
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 Another protein of interest which was uniquely present in AP and NS samples 
on Day 21 was osteocalcin (P02822). This protein is a marker for bone turnover and its 
presence in serum is an indicator of bone resorption (Cepelak & Cvoriscec, 2009). The 
presence of this protein, only in the serum of birds supplemented with AP and NS, 
could indicate that these products have an effect on bone formation in the early stages of 
life. Though no literature could be found linking YCW feeds to bone formation, the 
formation of bone, particularly in the early stages of life, is of critical importance in 
chicken husbandry. Leg problems are prevalent in broilers (Sanotra et al., 2001) and can 
lead to higher culling rates in commercial production systems which have real monetary 
effects on the producer (Cook, 2000). If these products are benefiting the formation of 
bone, it could lead to greater efficiencies in flock yield due to lower culling rates. 
 Iron depletion can be caused by dietary deprivation or malabsorption of iron and 
can lead to anemia (Huebers et al., 1990; Fernández-Bañares et al., 2009). The receptor 
responsible for binding and transport of iron is Transferrin receptor protein (TRP) 
(F1NTM6). TRP found in serum is the truncated form of TRP transmembrane protein 
that is found on the surface of virtually every cell (Huebers et al., 1990). Iron delivery 
to cells is mediated by the binding of cell surface TRP by serum TRP (Cook et al., 
1993). The level of serum TRP is directly related to the level of TRP on the surface of 
cells and the level of cell surface TRP has been previously seen to reflect iron 
requirement (Rao et al., 1985). The levels of serum TRP are comparable to the levels of 
available iron and increases in serum TRP have been linked with iron deficiency 
(Huebers et al., 1990). TRP abundance was significantly increased (p  <0.05) in NS and 
PT samples on Day 35 as well as increased and approaching significance (p = 0.054) in 
AP on Day 7. This increase in serum TRP could be an indicator of reduced iron levels 
in broiler chickens fed a diet supplemented with AP, NS and PT. Supplementation with 
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these YCW products may need to be coupled with an additional iron supplement in 
order to avoid this apparent reduction in iron levels.  
4.6.5 Vitamin A transport 
Vitamin A is of vital importance in the diet of the broiler chicken as it is not produced 
naturally by the animals and so must be obtained through the diet (Johnson & 
Schroeder, 1996). Deficiencies in broiler diets can lead to deterioration of reproductive 
(Clagett-Dame & DeLuca, 2002) and immunological health (Davis & Sell, 1983; Sklan 
et al., 1994). Vitamin A is bound by Retinol binding protein 4 (RBP4) (P41263) which 
is in turn bound to Transthyretin (P27731) (Zabetian-Targhi et al., 2015). These 
molecules then transport Vitamin A throughout the animal. Retinol binding protein 7 
(RBP7) (E1C0M1) is involved in the intracellular binding and transport of Vitamin A in 
cells (Hu et al., 2017). RBP4 was significantly increased (p < 0.05) and RBP7 was 
uniquely identified on in NS samples on Day 7. Transthyretin was significantly 
increased on Day 35 in AP samples and RBP7 was uniquely identified on Day 7, RBP4 
was also increased in abundance and approached significance (p = 0.08) on Day 21 
(Appendix 1-Table 7.1). Transthyretin was significantly increased on Day 35 in PT 
samples. Increases in the abundance of these proteins would indicate a greater 
abundance or availability of Vitamin A with the supplementation of these YCW 
products. Vitamin A was part of the basal diet at 1.3g/kg, 1.1g/kg and 1g/kg (starter, 
grower and finisher basal diet) (Table 2.1) in all feeds, so a greater abundance of 
Vitamin A would have to be obtained from the YCW products. One common source of 
Vitamin A is β-carotene which is a precursor to Vitamin A (Li et al., 2017). This 
molecule is naturally obtained through the consumption of carotenoid-producing 
organisms such as higher plants or photosynthetic microorganisms (Yamano et al., 
1994). A number of species of higher fungi produce carotenoids (Johnson & Schroeder, 
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1996), which would account for an increase in the abundance of Vitamin A with YCW 
supplementation. Higher levels of Vitamin A are beneficial as it could reduce the need 
for inorganic supplementation in the diet. 
4.6.6 Effect of Organic Selenium Supplementation 
Selenium is an essential element in the diet of broiler chickens and its supplementation 
has been seen to have beneficial effects on broiler health status and meat quality (Surai, 
2002; Choct et al., 2004; Surai & Fisinin, 2014). The dietary source of selenium can 
have an impact, as inorganic selenium is considered a pro-oxidant and organic selenium 
has been seen to be have greater bioavailability (Rayman, 2004; Peric et al., 2009; 
Lönnerdal et al., 2017).  
 Drip-loss has been linked to GSH-Px level (Choct et al., 2004). GSH-Px was 
increased in abundance in all treatment groups with the largest fold change noted in PT 
samples where it was increased and approaching significance on Day 21(Appendix 1 - 
Table 7.5) and Day 35 (Appendix 1-Table 7.5b). GSH-Px level has been previously 
shown to be influenced by selenium supplementation and a greater bioavailability of 
organic selenium from PT would explain this increased GSH-Px level. Additonally, 
with this increased GSH-Px level, there may be a reduction in drip-loss from the meat 
obtained from PT supplemented broilers. A reduction in drip-loss and increase in serum 
GSH-Px has been reported previously in birds supplemented with organic selenium 
rather than its inorganic form (Wang & Xu, 2008; Wang et al., 2011). This result was 
also matched in pigs with significantly higher (p < 0.01) levels of serum GSH-Px in 
organic selenium supplemented pigs at 0.2mg/kg and 0.3 mg/kg supplementation 
(Mahan et al., 1999). In this work,  selenium was also supplemented to broiler diets at 
0.3 mg/kg. 
 The effect of the absence of the potentially pro-oxidative inorganic selenium in 
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the diet of PT supplemented birds can also be seen in the significant reduction or 
absence of proteins involved in the detoxification of ROS: Catalase (n =2), 
A0A1D5PPU9 and Q5ZL24, which were also absent from PT samples on Day 7 and 
Day 21, respectively.  
 The protective effects of selenium have been seen in organs such as the liver and 
organic forms of selenium have been liked to reduced liver damage (Peric et al., 2009). 
Glutathione-S-Transferase α (αGST) (Q08392) is an enzyme involved in the 
detoxification of ROS and its alpha form is present in high concentrations in the cytosol 
of hepatic cells (Beckett & Hayes, 1993). This enzyme conjugates glutathione to ROS 
(Federico et al., 1999) and its presence in serum has previously been characterised as a 
biomarker for acute hepatitis or liver damage (Yukihiko et al., 1980). αGST is absent 
from the PT samples on Day 7, Day 21 and Day 35 which would indicate that this 
product is having some hepatoprotective effect on the broiler chicken. This reduction in 
liver damage could be due to the reduced level of oxidative damage with an organic 
selenium source, the greater bioavailability of organic selenium leading to increased 
levels of GSH-Px which is reducing oxidative damage or a dual effect of these two 
factors. 
 Evidence suggests that organic selenium has a greater bioavailability than its 
inorganic forms (Lönnerdal et al., 2017) and this hepatoprotective effect could also be a 
result of the greater bioavailability of organic selenium allowing greater protective 
potential of enzymes that make use of the element.  
 A greater bioavailability of organic selenium from PT is not only supported by 
the increased levels of GSH-Px on all days, but also by the higher number of proteins 
detected with SeMet/SeCys substitutions and the unique presence of Selenoprotein F 
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precursor in the serum of PT treated birds. An increased bioavailability could not only 
lead to increased benefits to the broiler chicken, but also to the producer and consumer. 
Increased bioavailability could reduce supplementation cost to the producer and 
increase levels of selenium produced meat and lead to increased selenium intake in the 
diet of the consumer. 
 In NS samples, GSH-Px was also seen to be increased in abundance on Day 7, 
which was also accompanied by a significant increase (p < 0.05) in two other enzymes 
involved in the detoxification of ROS: Glutaredoxin 3 (A0A1D5NW30) and 
Peroxiredoxin 6 (F1NBV0). EO, a component of the NS supplement, have been seen to 
mediate oxidative stress in animals (Zeng et al., 2015). Antioxidative effects of these 
EO have been achieved by stimulating the expression of a number of proteins which are 
involved in antioxidant activity (Kang et al., 2015; Zou, et al., 2016). EO have been 
previously seen to increase the serum concentration of GSH-Px as well as improve the 
total antioxidant capacity of weaned pigs (Zeng et al., 2015). Therefore, this increase in 
the abundance of proteins involved in the detoxification of ROS may not be due to an 
increased oxidative stress, but rather the stimulation of the production of these proteins 
by EO present in this feed supplement. 
4.6.7 Inter-Feed Comparison 
The significant alterations in proteins involved in a number of key processes would 
suggest that these products are having interesting effects on the health status of the 
broiler chicken that are measurable through proteomic analysis of serum. Overall effects 
of YCW supplementation include stimulation of the innate immune system, particularly 
the complement system, alterations in the levels of a number of proteins involved in the 
detoxification of a number of ROS, stimulation of metabolic processes, mucosal 
development and transport of iron and Vitamin A.  
130 
 
 The three YCW-based products showed some level of similarity regarding their 
effects, which would be expected from three related products. Individually, results did 
show that these three products did have product specific effects. 
 AP supplementation was seen to stimulate the immune system, possibly through 
the binding of the C-type lectin receptor, Surfactant Protein A, which was significantly 
increased in abundance on Day 7. This stimulation led to the increase in abundance of 
proteins involved in a number of processes in the innate immune system. AP showed 
the lowest level of complement stimulation in comparison to the other products with 
three complement components significantly increased (p < 0.05) on Day 35. 
Gastrokine-2 and osteocalcin were seen to be uniquely present in AP samples when 
compared to control which could indicate that this molecule may be playing some role 
in bone development and gastric mucosal homeostasis. AP supplementation also 
seemed to play a role in Vitamin A and iron levels of broilers. An increase in the 
abundance of TRP may indicate a depletion in iron levels with AP supplementation 
which may indicate a need for iron supplementation. 
 NS supplementation was also seen to have immunostimulatory effects with a 
number of proteins involved in innate immune function significantly increased (p < 
0.05) in abundance throughout the three time points. Complement stimulation was again 
seen on Day 35 with four complement components significantly increased (p < 0.05) in 
abundance. MBL was increased in abundance and approached significance which would 
explain the complement stimulation noted. A number of proteins involved in the 
detoxification of ROS were significantly increased in abundance with NS 
supplementation, which may indicate impact on the oxidative status of the animal. 
RBP4 was significantly increased (p < 0.05) and RBP7 was uniquely identified in NS 
samples which may indicate a greater abundance or availability of Vitamin A in birds 
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supplemented with NS. A significant increase (p < 0.05) in the abundance of TRP may 
indicate a depletion in iron levels with NS supplementation, again iron supplementation 
may be needed with this product. 
 PT supplementation seemed to have the greatest effect on the immune status of 
the animal with a significant increase in abundance of many proteins involved in the 
innate immune system and five out of six detected complement components 
significantly increased (p < 0.05) on Day 35, Complement C3 precursor 
(A0A1D5P9F9) exhibited no significant change in any feed treatment. Complement 
stimulation is likely through the binding of MBL by a mannose residue which resulted 
in a significant increase (p < 0.05) in the abundance of this protein on Day 35. The 
absence of αGST, a serum biomarker for liver damage, may indicate some 
hepatoprotective effects of this product which could be explained by the absence of 
potentially pro-oxidative, inorganic selenium supplementation. This is supported by a 
concomitant significant reduction (p <0.05) in the abundance of two proteins involved 
in the detoxification of ROS which would again indicate a lower level of oxidative 
stress. Another explanation for this protective effect is the greater bioavailability of 
organic selenium which led to an increased ability to protect against ROS, resulting in 
reduced liver damage. Organic selenium did seem to have an effect on selenium status 
of PT supplemented broilers with increases in the number of proteins detected with 
SelMet/SelCys residues, increases in the level of the selenoprotein GSH-Px and the 
unique presence of selenoprotein F precursor in PT samples with comparison to control. 
Serum TRP was significantly increased (p < 0.05) in PT samples on Day 35 which may 
























The modification applied to the Proteominer protocol facilitated an in-depth serum 
proteomic investigation into the effects of YCW supplementation on broiler chickens. 
This analysis revealed a number of interesting effects including (i) stimulation of the 
innate immune system, particularly the complement cascade, (ii) alterations to the 
oxidative status of the animal, (iii) stimulation of metabolic processes and (iv) possible 
alterations in nutrient transport. Similarities amongst the effects of the YCW products 
were seen, which is to be expected from three YCW-based feed supplements.  
 The area of animal proteomics is growing, though it still represents a relatively 
small part of proteomics as a whole (Bili et al., 2018). There is, therefore, no 
standardised protocol for the preparation of serum samples, from most animal species, 
for LC-MS/MS analysis. Proteominer™ Technology offers species-independent low 
abundant protein enrichment, which is tremendously useful in quantitative proteomics. 
However, proteomic samples enriched using the commercial elution buffer are 
incompatible with optimum LC-MS/MS analysis. This issue was resolved with this 
modification applied to the protocol. This modification facilitated a greater depth of 
proteomic analysis of the broiler serum proteome, in comparison to that achieved using 
a commercial elution buffer. With the introduction of this reagent, Proteominer™ has the 
potential to become a useful tool in species-independent protein depletion of proteomic 
samples with high dynamic range for proteomic analysis using MS technologies. This 
high dynamic range problem is not specific to serum. Meat proteomics (Bendixen et al., 
2011), plant proteomics (Fröhlich et al., 2012) and bacterial proteomics (Ben Mlouka et 
al., 2015) can all suffer from similar difficulties in the preparation of proteomic samples 
for LC-MS/MS analysis. For this reason, the implementation of LCR may not only be 
of use with serum proteomics but could serve as a valuable alternative in the proteomic 
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investigation of other sample types, particularly when investigating proteins of lower 
abundance. 
 Antibiotics, when used sub-therapeutically, have been seen to improve feed 
efficiencies, reducing cost for both consumer and producer (National Research Council, 
1999). The rise in awareness of antibiotic resistance, however, has led to the 
implementation of a number of bans on their use as growth promoters in animal 
husbandry (European Commission, 2003; Food and Drug Administration, 2013). These 
bans, combined with the ever-growing demand for poultry products (Alexandratos & 
Bruinsma, 2012), has meant that the poultry industry has come under pressure to find 
viable alternatives to antibiotics. Yeast and its derivatives have emerged as an 
alternative that possess great potential in both reducing pathogenic invasion (Yang et 
al., 2009) and beneficially stimulating the host immune response (Gao et al., 2003; 
Chae et al., 2006; Goodridge et al., 2009; Ganner & Schatzmayr, 2012; Dalonso et al., 
2015; Song et al., 2014; Hoving et al., 2018). The stimulation of the complement 
cascade herein seen in each of the YCW-supplemented avian groups, indicates an 
immunostimulatory effect which could provide some resistance against pathogenic 
infection (Samuelsen et al., 2015). This stimulatory effect could be further studied by 
the examination of the epithelial cells of the intestinal tract for signs of 
immunostimulation, possibly through qRT-PCR identification of cognate gene 
expression associated with immunostimulation. Further investigation of markers 
associated with immunostimulation could also be conducted using ELISA. 
 This immunostimulation may also be of benefit in the reduction of pathogenic 
infection. Narrow profit margins in livestock production often mean that preventative, 
rather than therapeutic measures, are more cost effective and feasible (Layton et al., 
2017). Preventative biosecurity measures such as decontamination, culling and 
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vaccination are all common practice in animal husbandry (Conan et al., 2012). For 
livestock, vaccination remains one of the most important tools in the prevention of 
infectious disease (Plotkin, 2005; Stokka & Goldsmith, 2015). Vaccination prevents the 
spread of infectious disease by generating a sufficient protective immune response to 
pathogenic microbes and can be in the form of attenuated pathogens, pathogen surface 
molecules or recombinant pathogen antigens (Li & Wang, 2015). One example of this 
process in broiler husbandry is Avian Influenza virus (AIV) (Peyr et al., 2009; 
Spackman & Pantin-Jackwood, 2014), which is one of the most economically important 
diseases affecting livestock (Layton et al., 2017). Many approaches can be used for 
combating AIV, however, vaccination is the only sustainable approach (Domenech et 
al., 2009). 
 In some cases, vaccines alone do not provide a sufficient immune response to 
provide protection (Sun et al., 2018). Adjuvants are substances co-administered with a 
vaccine which strengthen the host immune response to antigens leading to reduced 
dosage and production cost (Sun et al., 2018), and can lead to improved response 
magnitude and longevity of the vaccine-mediated protection (Reed et al., 2009). 
Examples of commonly used adjuvants are aluminium salts, oil emulsions, 
microparticles and polysaccharides (Sun et al., 2018).  
Polysaccharides have previously been defined as excellent vaccine adjuvant candidates 
as they have low toxicity, are capable of stimulating the immune response and have 
high biocompatibility (Petrovsky & Cooper, 2011). These molecules are capable of 
producing immune responses such as macrophage and monocyte stimulation and induce 
secretion of immune-related proteins such as cytokines and complement molecules 
(Young et al., 2001; Gantner et al., 2003; Brown, 2006; Levitz, 2010; Song et al., 
2014). β-glucans have adjuvant activity and are potent activators of the innate immune 
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system in both immunocompetent and immunocompromised individuals (Franzusoff et 
al., 2005; Munson et al., 2007). Yeast-derived β-glucan has been previously used to 
enhance IgG response to ovalbumin in both intradermal and oral administration (De 
Smet et al., 2014). Complement C5, which was seen to be significantly increased (p < 
0.05) in the serum of NS and PT supplemented birds, is the most potent anaphylatoxin 
generated through complement stimulation and has been seen to have adjuvant effects in 
teleost fish with higher IgM antibody level produced in response to a soluble antigen 
(Wu et al., 2014). Mannose Binding Lectin, which was seen to be increased in 
abundance in serum samples from YCW supplemented broilers, has been shown to 
participate in the protection of host against viral infection and plays a role in the 
vaccination of chickens against infectious bronchitis (Kjærup et al., 2014).  
With significant increases (p  < 0.05) in the abundance of a number of proteins involved 
in innate immune function, proteomic results would suggest that these products could 
augment the host response to vaccination, reducing the need for intradermal 
administration of adjuvants such as oil emulsion, which can cause issues at the site of 
infection (Li & Wang, 2015). 
 With the greater bioavailability of organic selenium (Rayman, 2004; Lönnerdal 
et al., 2017) and the potentially pro-oxidative effects of inorganic selenium (Peric et al., 
2009), there are a number of advantages to using selenium in its organic form for diet 
supplementation. Serum from PT supplemented broilers exhibited some effects that 
were not seen in other samples, such as a possible protective effect on the liver of the 
animals and alterations in the selenium status of the animal. These effects are possibly 
due to the organic selenium source available from PT which replaced the inorganic 
selenium supplement of the basal feed.  
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 Drip-loss can reduce the weight of meat products, affecting its monetary value 
(Fischer, 2007), and has become synonymous with low meat quality in the last number 
of decades (Northcutt et al., 1994). Dietary selenium supplementation has been linked 
to increased levels of glutathione peroxidase in the muscle (Pappas et al., 2005; Wang 
et al., 2011; Zhou & Wang, 2011; Cai et al., 2012) of chickens. This enzyme has been 
linked to reduced drip-loss and improved meat quality (Choct et al., 2004). With 
apparent increases in the levels of selenium and glutathione peroxidase in broiler 
chickens supplemented with PT, improved meat quality is a possibility. 
Several tests for meat quality exist such as water carrying capacity test (Sun & Luo, 
1993), filter paper test for drip-loss (Kauffman et al., 1986) and breast hardness test 
(Sun & Luo, 1993). One possible avenue of future study is to examine the meat quality 
of broilers supplemented with PT versus a control basal feed, using one or all of these 
meat quality tests. Improved meat quality which would likely improve the monetary 
value of meat produced which is of benefit to the producer.  
Increases in the selenium levels are not just of benefit to the producer. Selenium is an 
essential element in the human diet and deficiencies have been found in some 
socioeconomic groups (Thiry et al., 2013; Hargreaves et al., 2014). Selenium-enriched 
foods are a helpful supplement in maintaining healthy levels (Thiry et al., 2013) and 
broilers with increased levels of selenium in the muscle tissue could help to mitigate 
selenium deficiencies in these economic groups. Testing broiler muscle tissue for 
selenium content using techniques such as inductively coupled plasma mass 
spectrometry (ICP-MS) (Bou et al., 2004; Gerber et al., 2009) could provide more 
information on the selenium levels available to consumers. 
 Quantitative proteomic results from sera of broilers supplemented with PT were 
consistent with a hepatoprotective effect on the broiler chicken given the specific 
138 
 
undetectability of αGST, a biomarker for liver damage (Yukihiko et al., 1980; Rees et 
al., 1995) in treated animals. Interestingly, this is in accordance with observations of 
Peric et al. (2009) which showed that dietary organic selenium led to significant 
reductions in the levels of both alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST), which are biomarkers of heptotoxicity (e.g., due to oxidative 
damage), when compared to inorganic supplementation. More investigation is needed 
here but could reveal an added benefit to supplementation with this product. A αGST 
Enzyme-Linked Immunosorbent Assay (ELISA) analysis (Rees et al., 1995) could be 
conducted on serum from PT supplemented birds in order to further evaluate and 
explore our obervations relating to dietary PT supplementation. 
A number of uncharacterised proteins have been identified as significantly changed in 
abundance (p <0.05) in this study. It is conceivable that some of these may have 
prognostic or predictive value with respect to feed efficacy. Consequently, cloning and 
recombinant expression of selected proteins, followed by antibody generation could 
facilitate immunoblot and/or ELISA development to readily detect alterations in 
abundance of these antigens in avian serum in response to feed products. It may also aid 
immunolocalisation studies to provide insight into in vivo localisation of proteomic 
changes. Such work is strongly warranted should the sponsor endeavour to extract all 
available value from the completed tasks. 
 To conclude: This thesis has, using a novel sample preparation techonlogy, 
demonstrated a number of biological effects of three YCW products on the broiler 
chicken using serum LC-MS/MS analysis. Serum samples were prepared for LC-
MS/MS using Proteominer™ technology with the implementation of an alternative 
buffer, LCR. Quantitative proteomic analysis highlighted a number of effects, namely 
immunostimulation, alterations to the oxidative status of the animals, stimulation of 
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metabolic processes and possible hepatoprotection. These results represent areas of 
possible future investigation which could lead to advancements in the field of animal 
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7.1 Enzyme Linked Immunosorbent Assay to examine Alpha-1-Acid Glycoprotein 
abundance change in NS samples. 
In order to confirm the high fold change (Log2 Fold Change = 2.12) detected in Alpha 1 Acid 
Glycoprotein (A1AGP) of NS samples on Day 35, a chicken A1AGP enzyme-linked 
immunosorbent assay (ELISA) (ab157690) (abcam
®
) was conducted on pooled Control and 
NS samples from Day 35. Three pooled serum samples from Day 35 of NS and Control were 
tested for A1AGP concentration. As high variability was seen in the first assay (Figure 7.1) 
the assay was repeated (Figure 7.2). High variability was seen in assay results. Results 
showed a trend that indicated an increase in A1AGP levels though the high fold change 





















Figure 7.1: Bar chart representing the Alpha-1-Acid Glycoprotein concentration in pooled 
serum samples from Control and NS fed birds following the first Enzyme Linked 




















Figure 7.2: Bar chart representing the Alpha-1-Acid Glycoprotein concentration in pooled 
serum samples from Control and NS fed birds following the second ELISA. Error bars denote 










7.2 Proteins approaching significance and proteins with large fold changes.  
Each treatment group was searched for proteins of note with a p-value approaching 
significance (p <0.08). AP had 36 proteins approaching significance, these are listed in 
Table 7.1. NS had 46 proteins approaching significance, these are listed in Table 7.2. PT 
had 48 proteins of note approaching significance, these are listed in Table 7.3.  
Each treatment group was also searched for proteins of note with high fold changes 
(Fold Change > 1.8). AP had 10 proteins of note with high fold changes, these are listed 
in Table 7.4. NS had 2 proteins with high fold changes, these are listed in Table 7.5. PT 

























p value Accession 
Transferrin receptor protein 1 2.01 10 18.3 Day 35 0.06 F1NTM6 
Uncharacterized protein 1.36 6 45.3 Day 21 0.05 A0A1D5PUI7 
Uncharacterized protein 0.86 6 16.8 Day 35 0.08 E1C206 
Uncharacterized protein 0.86 82 63.0 Day 35 0.06 E1BRS7 
Eukaryotic translation initiation 
factor 1 
0.72 5 79.6 Day 21 0.06 R4GLE6 
Eukaryotic initiation factor 4A-II 0.72 6 24.0 Day 7 0.06 R9PXN1 
Alkaline phosphatase 0.71 16 42.8 Day 21 0.07 Q92058 
Retinol-binding protein 4 0.66 14 70.9 Day 21 0.08 P41263 
Uncharacterized protein 0.64 16 49.4 Day 21 0.06 E1BS56 
T-complex protein 1 subunit zeta  0.64 12 36.2 Day 35 0.07 Q5ZJ54 
Uncharacterized protein 0.54 2 14.8 Day 7 0.06 F1N9T1 
Uncharacterized protein 0.53 32 70.9 Day 21 0.07 F1NVF3 
Uncharacterized protein 0.40 8 45.5 Day 7 0.07 A0A1D5PAH2 
Glutathione peroxidase 0.38 11 48.2 Day 7 0.06 F1NPJ8 
Plasminogen 0.37 50 61.2 Day 21 0.08 F1NWX6 
Collagen type XI alpha 1 chain 0.29 7 18.6 Day 21 0.06 A0A1D5PVT6 
Uncharacterized protein 0.29 3 30.2 Day 7 0.08 F1N9A3 
Uncharacterized protein 0.28 16 31.7 Day 21 0.07 F1P4N9 
Apolipoprotein A-I 0.19 55 92.8 Day 21 0.07 P08250 
G protein subunit beta 1 -0.19 4 18.2 Day 7 0.07 F1NLV4 
Uncharacterized protein -0.25 30 31.2 Day 7 0.07 A0A1D5PEF7 
Fibulin-1 -0.26 18 38.5 Day 21 0.05 A0A1L1RU28 
Uncharacterized protein -0.38 4 52.9 Day 21 0.06 A0A1L1RML6 
Uncharacterized protein -0.39 6 35.7 Day 7 0.08 R4GFI8 
MHC class II beta chain 2 -0.46 3 18.6 Day 21 0.06 A5HUL4 
Cathepsin B -0.48 17 60.9 Day 35 0.07 A0A1L1RS19 
F-actin-capping protein subunit 
alpha-1  
-0.50 6 33.9 Day 35 0.05 P13127 
Chemokine -0.64 4 48.9 Day 35 0.07 E1C733 
Uncharacterized protein -0.65 2 38.2 Day 7 0.07 F1NSD3 
Elastin -0.65 3 6.1 Day 35 0.06 P07916 
Uncharacterized protein -0.66 27 52.1 Day 35 0.07 F1NAB7 
Histone H2A.J  -0.66 4 32.6 Day 7 0.05 P70082 
Tubulin beta-7 chain -0.69 12 46.4 Day 21 0.07 P09244 
Myosin light polypeptide 6 -0.74 4 27.2 Day 35 0.06 P02607 
Hemoglobin subunit beta  -0.79 9 76.2 Day 7 0.05 P02112 
Lamin-A -0.93 17 28.3 Day 7 0.08 P13648 
 
 
Table 7.2. Proteins with high fold change (Fold Change >1.8) in sera from Actigen®-




















p value Accession 
Alpha-1-acid glycoprotein 3.69 7 36.0 Day 35 0.37 Q8JIG5 
Uncharacterized protein 2.61 11 24.4 Day 35 0.31 E1C8N1 
Neuronal-glial cell adhesion molecule  2.60 14 21.6 Day 35 0.18 Q03696 
Transferrin receptor protein 1 2.01 10 18.3 Day 35 0.06 F1NTM6 
Uncharacterized protein 1.98 25 63.0 Day 35 0.53 A0A1L1S0P1 
Hemoglobin subunit beta 1.97 15 88.4 Day 35 0.19 P02112 
Insulin like growth factor binding protein 
acid labile subunit 
1.86 12 31.1 Day 35 0.17 F1NI07 
Ovotransferrin 1.85 50 74.6 Day 35 0.32 A0A1D5P4L7 
Hemopexin 1.82 23 81.7 Day 35 0.41 H9L385 
Creatine kinase M-type  -1.81 19 51.4 Day 21 0.26 P00565 
 
 










p value Accession 
Uncharacterized protein 1.27 10 48.7 Day 35 0.08 A0A1D5PW77 
Neuronal-glial cell adhesion 
molecule  
1.26 14 21.6 Day 35 0.05 Q03696 
Lamin-A 1.12 21 34.4 Day 35 0.07 P13648 
Uncharacterized protein 0.83 8 37.1 Day 35 0.07 F1NXB6 
Transthyretin 0.74 9 72.7 Day 35 0.06 P27731 
Uncharacterized protein 0.70 7 13.5 Day 35 0.06 E1BYS3 
Dihydropyrimidinase-related protein 
2  
0.62 14 38.3 Day 7 0.07 Q90635 
Uncharacterized protein 0.57 4 46.3 Day 7 0.08 A0A1D5P5P6 
Uncharacterized protein 0.53 2 38.5 Day 7 0.05 F1NSC8 
T-complex protein 1 subunit theta 0.53 8 21.0 Day 7 0.06 F1NEF2 
Uncharacterized protein 0.50 11 34.5 Day 21 0.08 E1BS40 
Uncharacterized protein 0.49 3 12.1 Day 7 0.07 F1NNV6 
Prolyl 4-hydroxylase subunit alpha-2  0.49 6 20.4 Day 7 0.07 Q5ZLK5 
Uncharacterized protein 0.49 4 8.3 Day 7 0.08 A0A1D5PQR2 
Uncharacterized protein 0.48 13 27.8 Day 7 0.08 A0A1D5P2H3 
Uncharacterized protein 0.45 5 52.9 Day 7 0.06 A0A1D5PH37 
Uncharacterized protein 0.42 19 48.5 Day 7 0.06 E1BS40 
Uncharacterized protein 0.41 26 41.1 Day 35 0.06 A0A1D5PBP6 
Uncharacterized protein 0.41 18 29.1 Day 35 0.06 A0A1L1S0T3 
Plasminogen 0.38 54 68.9 Day 35 0.06 R4GMH5 
Uncharacterized protein 0.35 8 58.2 Day 35 0.06 E1BY93 
Uncharacterized protein 0.30 30 70.2 Day 7 0.07 F1NVF3 
Uncharacterized protein 0.22 16 30.6 Day 35 0.05 F1P4N9 
Collagen alpha-1(X) chain 0.20 5 10.7 Day 35 0.07 P08125 
Uncharacterized protein -0.16 6 10.6 Day 21 0.06 F7B5K7 
Uncharacterized protein -0.22 30 31.2 Day 7 0.06 A0A1D5PEF7 
Coatomer subunit epsilon  -0.29 3 18.8 Day 21 0.08 Q5ZIK9 
Peroxiredoxin-1  -0.29 8 53.8 Day 35 0.07 P0CB50 
Collagen alpha-2(I) chain  -0.30 11 12.7 Day 35 0.07 P02467 
Uncharacterized protein -0.36 18 9.7 Day 7 0.08 A0A1D5NXE0 
Uncharacterized protein -0.37 10 54.9 Day 35 0.05 A0A1D5NTE9 
Secreted phosphoprotein 24 -0.40 8 51.0 Day 35 0.06 Q710A0 
Collagen alpha-1(VI) chain -0.44 12 19.0 Day 7 0.07 A0A1D5PWN6 
Uncharacterized protein -0.45 9 33.1 Day 21 0.06 E1C1G8 
S-formylglutathione hydrolase -0.47 6 45.0 Day 21 0.06 A0A1L1RWZ4 
Uncharacterized protein -0.49 3 5.0 Day 7 0.08 A0A1D5NV10 
Creatine kinase B-type -0.51 9 42.0 Day 35 0.07 A0A1L1RVT1 





















p value Accession 
Low molecular weight 
phosphotyrosine protein phosphatase  
-0.60 9 69.0 Day 21 0.05 Q5ZKG5 
Uncharacterized protein -0.65 8 26.2 Day 21 0.06 A0A1D5PAN0 
Low molecular weight 
phosphotyrosine protein phosphatase  
-0.65 10 70.3 Day 35 0.05 Q5ZKG5 
Dihydropyrimidinase-related protein 
2 
-0.70 7 22.4 Day 21 0.07 Q90635 
Glycerol-3-phosphate dehydrogenase -0.72 12 51.6 Day 21 0.07 A0A1D5P1Y7 
Peroxiredoxin-1 -0.80 6 44.7 Day 21 0.06 P0CB50 
Adenylate kinase isoenzyme 1  -0.84 11 63.9 Day 21 0.05 P05081 
Creatine kinase M-type -1.15 17 60.1 Day 35 0.06 P00565 






p value Accession 
Mannose-binding protein 0.414 8 32.7 Day 35 0.16 Q98TA4 
Beta-hexosaminidase 0.27 20 54.1 Day 7 0.09 F1NTQ2 
Beta-enolase -1.2 12 41 Day 21 0.09 P07322 
Alpha-amylase 0.8 19 61.7 Day 7 0.08 A0A1D5PUZ5 






p value Accession 
ATP synthase subunit beta 3.68 12 34.1 Day 35 0.43 Q5ZLC5 




Table 7.5. Proteins of note approaching significance in sera from PT-supplemented 
broilers. 






p value Accession 
Uncharacterized protein 1.34 10 48.7 Day 35 0.07 A0A1D5PW77 
Uncharacterized protein 0.93 10 32.9 Day 7 0.05 A0A1D5PAN0 
Proteasome subunit alpha type  0.89 6 13.1 Day 35 0.06 E1C7I7 
Uncharacterized protein 0.89 6 34.2 Day 7 0.07 E1BQD1 
Uncharacterized protein 0.85 8 37.1 Day 35 0.06 F1NXB6 
14-3-3 protein zeta 0.83 5 28.1 Day 7 0.08 A0A1L1RRT9 
Dihydropyrimidinase-related protein 2  0.76 14 38.3 Day 7 0.08 Q90635 
Uncharacterized protein 0.60 24 62.7 Day 21 0.05 F1NMN2 
Retinol-binding protein 4 0.51 14 70.9 Day 21 0.06 P41263 
Uncharacterized protein 0.48 13 37.1 Day 21 0.08 A0A1D5PU00 
Collagen type XI alpha 1 chain 0.46 8 18.7 Day 35 0.07 A0A1D5PVT6 
Ribonuclease/angiogenin inhibitor 1 0.43 7 25.4 Day 7 0.07 Q5ZIY8 
Uncharacterized protein 0.43 16 31.7 Day 21 0.07 F1P4N9 
Uncharacterized protein 0.41 10 23.5 Day 7 0.06 A0A1L1S099 
Uncharacterized protein 0.41 5 52.9 Day 7 0.07 A0A1D5PH37 
Uncharacterized protein 0.40 4 8.3 Day 7 0.07 A0A1D5PQR2 
Proteasome subunit alpha type  0.38 5 41.1 Day 21 0.07 F1NEQ6 
Glutathione peroxidase 0.36 14 56.0 Day 21 0.08 F1NPJ8 
Ribosomal protein S14 0.34 4 49.7 Day 7 0.08 Q5ZHW8 
Tubulin alpha chain 0.34 75 60.2 Day 35 0.06 F1NK40 
Collagen type XVIII alpha 1 chain 0.33 5 6.0 Day 21 0.05 A0A1D5P5M7 
C-type lectin domain family 3 
member B  
0.28 11 67.7 Day 21 0.08 Q9DDD4 
Peroxiredoxin-6 0.26 12 68.3 Day 7 0.07 F1NBV0 
Prolyl 4-hydroxylase subunit alpha-2  0.26 6 20.4 Day 7 0.06 Q5ZLK5 
Uncharacterized protein 0.24 15 65.2 Day 35 0.08 F1NHT5 
F-actin-capping protein subunit beta 
isoforms 1 and 2  
-0.21 11 57.0 Day 21 0.06 P14315 
Coatomer subunit epsilon -0.35 3 18.8 Day 21 0.06 Q5ZIK9 
Coatomer subunit epsilon  -0.40 10 15.5 Day 35 0.06 A0A1D5PWN6 
Retinol-binding protein 4  -0.42 19 61.6 Day 35 0.05 A0A1D5P380 
Uncharacterized protein -0.42 15 47.3 Day 35 0.07 A0A1L1RW44 
Tubulin alpha chain -0.43 11 44.6 Day 21 0.07 A0A1D5PC38 
Elongation factor 1-alpha 1  -0.46 18 50.0 Day 35 0.07 Q90835 
Uncharacterized protein -0.48 10 9.4 Day 35 0.06 P02457 
C-type lectin domain family 3 
member B  










Table 7.6. Proteins with high fold change in sera from PowerTract® supplemented 
broilers. 






p value Accession 
Uncharacterized protein -0.57 3 24.7 Day 35 0.05 A0A1L1RUZ7 
Uncharacterized protein -0.59 5 24.1 Day 21 0.06 A0A1D5PGB2 
Ubiquitin-40S ribosomal protein 
S27a 
-0.64 3 28.2 Day 7 0.07 P79781 
Uncharacterized protein -0.64 7 37.3 Day 21 0.06 A0A1D5PKX1 
Uncharacterized protein -0.65 8 42.7 Day 35 0.07 A0A1D5P4K6 
Uncharacterized protein -0.71 18 53.6 Day 35 0.06 P09207 
Collagen type XVIII alpha 1 chain -0.72 18 60.1 Day 35 0.05 Q5ZLJ7 
Matrilin-3 -0.75 13 32.5 Day 7 0.06 O42401 
Complement C6  -0.77 17 26.5 Day 7 0.07 B8ZX71 
Collagen alpha-1(VI) chain -0.79 12 19.0 Day 7 0.07 A0A1D5PWN6 
F-actin-capping protein subunit beta 
isoforms 1 and 2  
-0.89 12 46.8 Day 35 0.06 A0A1D5P342 
Glycerol-3-phosphate dehydrogenase  -0.93 12 51.6 Day 21 0.08 A0A1D5P1Y7 
Myosin light polypeptide -1.00 4 27.2 Day 35 0.07 P02607 
Glycerol-3-phosphate dehydrogenase -1.06 2 8.6 Day 35 0.06 Q9PUU8 
Uncharacterized protein 1.34 10 48.7 Day 35 0.07 A0A1D5PW77 






p value Accession 
Glutathione peroxidase 0.78 15 58.3 Day 35 0.09 F1NPJ8 






p value Accession 
Creatine kinase M-type  3.12 19 51.4 Day 21 0.13 P00565 
Hemoglobin subunit alpha-D 2.11 17 93.6 Day 21 0.41 P02001 
Alpha-1-acid glycoprotein -1.86 7 36.0 Day 35 0.36 Q8JIG5 
 
 
Table 7.7. List of known selenoproteins obtained from Liu et al. (2017).  
Glutathione peroxidase 1 Selenoprotein H 
Glutathione peroxidase 2 Selenoprotein I 
Glutathione peroxidase 3 Selenoprotein M 
Glutathione peroxidase 4 Selenoprotein N 
Iodothyronine deiodinase 1 Selenoprotein O 
Iodothyronine deiodinase 2 Selenoprotein U 
Iodothyronine deiodinase 3 Selenoprotein W 
Methionine sulfoxide reductase B Thioredoxin reductase 1 
Selenophosphate Synthetase 1 Thioredoxin reductase 2 
Selenophosphate Synthetase2 Thioredoxin reductase 3 
Selenoprotein 15 
 
 
 
